<?xml version="1.0" encoding="UTF-8"?>
<definitions publication-date="2025-01-01" publication-type="official">
<definition-item date-revised="2025-01-01"><classification-symbol scheme="cpc">C12N</classification-symbol><definition-title>MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA  (microbiological testing media <class-ref scheme="cpc">C12Q1/00</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Microorganisms (e.g. protozoa, bacteria, fused plant cells, hybridomas, viruses, animal cells or tissue, stem cells, tumour cells) and enzymes or proenzymes and compositions containing microorganisms and enzymes or proenzymes.</paragraph-text></list-item><list-item><paragraph-text type="body">Processes for preparing, activating, inhibiting, separating, or purifying enzymes.</paragraph-text></list-item><list-item><paragraph-text type="body">Treatment of microorganisms or enzymes with electrical or wave energy.</paragraph-text></list-item><list-item><paragraph-text type="body">Processes of reproducing, maintaining, or preserving microorganisms or compositions thereof.</paragraph-text></list-item><list-item><paragraph-text type="body">Processes of preparing or isolating a composition containing microorganisms.</paragraph-text></list-item><list-item><paragraph-text type="body">Preparing mutants and screening processes therefor.</paragraph-text></list-item><list-item><paragraph-text type="body">Processes of fusing two or more cells to each other.</paragraph-text></list-item><list-item><paragraph-text type="body">Recombinant DNA-technology including:</paragraph-text></list-item><list-item><paragraph-text type="body">Processes for manipulating genetic material;</paragraph-text></list-item><list-item><paragraph-text type="body">Processes of preparing, isolating and purifying nucleic acids;</paragraph-text></list-item><list-item><paragraph-text type="body">Methods for the introduction of genetic material into microorganisms using vectors or other expression systems, using microencapsulation, using microinjection, and other ways;</paragraph-text></list-item><list-item><paragraph-text type="body">Methods of regulating gene expression;</paragraph-text></list-item><list-item><paragraph-text type="body">Non-coding nucleic acid sequences, e.g. Promoters, operators, enhancers, suppressors, silencers, locus control regions, antisense nucleic acids, and aptamers, used in regulating gene expression or in other recombinant DNA technology related methods.</paragraph-text></list-item><list-item><paragraph-text type="body">Genes, per se; and vectors and expression systems, per se.</paragraph-text></list-item><list-item><paragraph-text type="body">Media for supporting or sustaining the growth of microorganisms.</paragraph-text></list-item></list></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">In subclasses&#160;<class-ref scheme="cpc">C12M</class-ref> - <class-ref scheme="cpc">C12Q</class-ref>, in the absence of an indication to the contrary, classification is made in the last appropriate subclass of subclasses&#160;<class-ref scheme="cpc">C12M</class-ref> - <class-ref scheme="cpc">C12Q</class-ref>.</paragraph-text><paragraph-text type="subheading">Multiple Classification</paragraph-text><list><list-item><paragraph-text type="body">Compositions, physical forms, methods of application of specific materials of the use of single compounds or compositions as biocides, pest repellants, pest attractants, pesticides, herbicides or plant growth regulators are further classified in subclass&#160;<class-ref scheme="cpc">A01N</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Biocidal, pest repellant, pest attractant, or&#160;plant&#160;growth regulatory activity of&#160;chemical compounds&#160;or&#160;preparations&#160;is further classified in&#160;<class-ref scheme="cpc">A01P</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Therapeutic activity of compounds containing microorganisms, single cell proteins, or enzymes, is further classified in subclass&#160;<class-ref scheme="cpc">A61P</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Uses of cosmetics or similar toilet preparations containing microorganisms or enzymes are further classified in subclass&#160;<class-ref scheme="cpc">A61Q</class-ref>.</paragraph-text></list-item></list><paragraph-text type="body">It is desirable to add subclass&#160;<class-ref scheme="cpc">C12R</class-ref>&#160;for microorganisms which are considered to be of interest for search.</paragraph-text></section-body></relationship><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Microbiological testing media </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><application-references><section-title>Application-oriented references</section-title><section-body><paragraph-text type="preamble">Examples of places where the subject matter of this place is covered when specially adapted, used for a particular purpose, or incorporated in a larger system:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">New breeds of multicellular plants, e.g. non-transgenic plants, and processes of obtaining these plants</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01H</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">New breeds of multicellular animals, e.g. transgenic animals, and processes of obtaining these animals</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01K67/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Compositions and use of the compositions and compounds for preservation of bodies of humans or animals or parts thereof</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01N1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Compositions and use of the compositions and compounds for preservation of plants or parts thereof</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01N3/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Biocides, pest repellents or attractants or plant growth regulators containing microorganisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, microorganisms or animal material</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01N63/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bakery products which may contain microorganisms or enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A21D10/00</class-ref>, <class-ref scheme="cpc">A21D13/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Foods or foodstuffs containing microorganisms or enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Body treating or pharmaceutical preparations containing microorganisms or enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K31/7088</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bandages, dressings or absorbent pads for physiological fluids containing microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61L15/36</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bandages, dressings or absorbent pads for physiological fluids containing enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61L15/38</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Biological compost</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C05F9/04</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Organic fertilizers containing added bacterial cultures, mycelia or the like</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C05F11/08</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzyme containing detergent compositions</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C11D</class-ref></paragraph-text></table-column></table-row></table></section-body></application-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Preservation of excised living parts of the human or animal body </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01N1/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Food compositions</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A21</class-ref>, <class-ref scheme="cpc">A23</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61L</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleic acids not used in recombinant technology and their chemical preparation </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Compositions, characterized by the use of bacteria, which are used to enhance recovery of hydrocarbons from underground formations</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C09K8/582</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">In this subclass, with the exception of group&#160;<class-ref scheme="cpc">C12N5/06</class-ref>, in the absence of an indication to the contrary, classification is made in the last appropriate place.</paragraph-text><paragraph-text type="body">In this subclass, viruses, human, animal, or plant cells, protozoa, tissues, and unicellular algae are considered as microorganisms.</paragraph-text><paragraph-text type="body">Overview of relevant orthogonal Indexing symbols:</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N2500/00</class-ref>:</paragraph-text><paragraph-text type="body">Indexing symbols intended for the nutritive components of culture media in combination with&#160;<class-ref scheme="cpc">C12N5/0018</class-ref>&#160;(generic media) or&#160;<class-ref scheme="cpc">C12N5/06</class-ref>&#160;and subgroups (specific media)&#8212;but effects beyond nutrition are not excluded. There is some aspect of classification by pathway in that&#160;<class-ref scheme="cpc">C12N2500/10</class-ref>&#160;and subgroups cover metals as well as metal chelators. Note that&#160;<class-ref scheme="cpc">C12N2500/25</class-ref>&#160;substitutes for any combination of&#160;<class-ref scheme="cpc">C12N2500/05</class-ref>&#160;(for sele&#8203;nium),&#160;<class-ref scheme="cpc">C12N2500/24</class-ref>&#160;(transferrin/iron) and&#160;<class-ref scheme="cpc">C12N2501/33</class-ref>&#160;(insulin). An example of &quot;undefined extract&quot; is Bovine Pituitary Extract (BPE),&#160;<class-ref scheme="cpc">C12N2500/84</class-ref>; serum is not indexed as undefined extract since codes are provided for its explicit absence.&#160;<class-ref scheme="cpc">C12N2500/02</class-ref>&#160;codes for explicitly low (or high) O<sub>2</sub> pressure, not for the &quot;usual&quot; 5% CO<sub>2</sub>. Antibiotics are not foreseen in the scheme.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N2501/00</class-ref>:</paragraph-text><paragraph-text type="body">Indexing symbols intended for biologically active agents in culture and differentiation processes in combi&#8203;na&#8203;tion with&#160;<class-ref scheme="cpc">C12N5/06</class-ref>&#160;and subgroups or&#160;<class-ref scheme="cpc">C12N5/0018</class-ref>. Indexation is made at the most relevant place, taking account of the biological pathway involved and not the chemical structure, unlike apparently similar hierar&#8203;chies such as those found in&#160;<class-ref scheme="cpc">C07K14/00</class-ref>&#160;or&#160;<class-ref scheme="cpc">A61K38/00</class-ref>; e.g.OKT3 antibody&#160;<class-ref scheme="cpc">C12N2501/515</class-ref>, staurosporine&#160;<class-ref scheme="cpc">C12N2501/727</class-ref>&#160;(tyrosine kinase inhibitor), KAAD-cyclopamine&#160;<class-ref scheme="cpc">C12N2501/41</class-ref>&#160;(interferes with Hedgehog pathway), copper salts&#160;<class-ref scheme="cpc">C12N2500/20</class-ref>&#160;(more specific symbols under&#160;<class-ref scheme="cpc">C12N2500/00</class-ref>&#160;take precedence over&#160;<class-ref scheme="cpc">C12N2501/00</class-ref>). Where pathways intersect or overlap, precedence is given to the most specific symbol and multiple classification may well be considered. Head symbols (<class-ref scheme="cpc">C12N2501/10</class-ref>, <class-ref scheme="cpc">C12N2501/20</class-ref>, <class-ref scheme="cpc">C12N2501/30</class-ref>, etc.) should be used only for specific agents not (yet) foreseen in the detailed scheme.&#160;<class-ref scheme="cpc">C12N2501/998</class-ref> -&#160;<class-ref scheme="cpc">C12N2501/999</class-ref>&#160;serve as repository for proteins and chemicals which do not fit (yet) within the scheme.&#160;<class-ref scheme="cpc">C12N2501/50</class-ref>&#160;and sub-symbols, are not intended to code for markers used in purification and/or identification of cells. (These are intrinsic properties of the cells, not reagents.)</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N2502/00</class-ref>:</paragraph-text><paragraph-text type="body">Complements the&#160;<class-ref scheme="cpc">C12N2500/00</class-ref>&#160;and&#160;<class-ref scheme="cpc">C12N2501/00</class-ref>&#160;series to indicate conditioned media or co-culture conditions. Also used to index the components of artificial constructs and tissue equivalents: see&#160;<class-ref scheme="cpc">C12N5/0697</class-ref>.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N2506/00</class-ref>:</paragraph-text><paragraph-text type="body">Symbols for &quot;remarkable&quot; differentiation processes, i.e.:</paragraph-text><list><list-item><paragraph-text type="body">differentiation from one lineage to a different one, &quot;lineages&quot; being understood as the three dot hierarchies under&#160;<class-ref scheme="cpc">C12N5/0602</class-ref>, (i.e. going from&#160;<class-ref scheme="cpc">C12N5/0603</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12N5/0693</class-ref>).</paragraph-text></list-item><list-item><paragraph-text type="body">differentiation of pluripotent cells (ES&#160;<class-ref scheme="cpc">C12N5/0606</class-ref>, EG&#160;<class-ref scheme="cpc">C12N5/0611</class-ref>, iPS&#160;<class-ref scheme="cpc">C12N5/0696</class-ref>, multipotent adult stem cells&#160;<class-ref scheme="cpc">C12N5/0607</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body">and also dedifferentiation, i.e. going backwards from a differentiated cell type to the corresponding stem/progenitor.&#160;</paragraph-text></list-item></list><paragraph-text type="body">&quot;Typical&quot; differentiation processes from a lineage-specific stem/progenitor cell to its regular progeny within the same lineage should not be indexed.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N2506/00</class-ref>&#160;is occasionally used to index files pertaining to &quot;rejuvenation&quot; without any actual, specific and characterized/type-able resulting product (see&#160;<class-ref scheme="cpc">C12N5/16</class-ref>).</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N2509/00</class-ref>:</paragraph-text><paragraph-text type="body">Used to spot the use of specific enzymes to digest tissues, i.e. not regular dispase/collagenase, or the use of very precise conditions for digestion.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N2510/00</class-ref>:</paragraph-text><paragraph-text type="body">Introduced with the closure of&#160;<class-ref scheme="cpc">C12N5/10</class-ref>.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N2517/00</class-ref>:</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N2517/02</class-ref>&#160;and&#160;<class-ref scheme="cpc">C12N2517/04</class-ref>&#160;pertain to isolated cells from a transgenic or cloned animal (<class-ref scheme="cpc">A01K67/00</class-ref>, <class-ref scheme="cpc">C12N15/00</class-ref>&#160;with&#160;<class-ref scheme="cpc">A01K</class-ref>); in most cases, such documents do not actually belong to&#160;<class-ref scheme="cpc">C12N5/00</class-ref>.&#160;<class-ref scheme="cpc">C12N2517/10</class-ref>&#160;docu&#8203;ments pertain to cultivation steps which belong to&#160;<class-ref scheme="cpc">C12N5/00</class-ref>&#160;(e.g. synchronisation of cells for nuclear transfer, maturation of oocytes for fecundation), although the ultimate purpose is still outside of&#160;<class-ref scheme="cpc">C12N5/00</class-ref>&#160;and the document should be circulated accordingly.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N2531/00</class-ref>:</paragraph-text><paragraph-text type="body">Used in combination with&#160;<class-ref scheme="cpc">C12N5/06</class-ref>&#160;(use of microsupports with a specific cell type).</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N2533/00</class-ref>:</paragraph-text><paragraph-text type="body">Used in combination with <class-ref scheme="cpc">C12N5/0068</class-ref> (mostly), but also <class-ref scheme="cpc">C12N5/0012</class-ref> and <class-ref scheme="cpc">C12N5/06</class-ref>. Codes may be given either for the base material of the support or for coatings on said support.</paragraph-text><paragraph-text type="subheading">Combination Sets (C-Sets):</paragraph-text><paragraph-text type="body">In this subclass, C-Sets classification is applied to the following groups, listed in the table below, if the document discloses a pertinent combination of technical features that cannot be covered by the allocation of a single symbol. The fourth column of the table indicates the place where the detailed information about the C-Sets construction and the associated syntax rules can be found, in the definition section &quot;Special rules of classification&quot;.</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">C-SETS ID</paragraph-text></table-column><table-column><paragraph-text type="body">BASE SYMBOL</paragraph-text></table-column><table-column><paragraph-text type="body">SUBSEQUENT SYMBOLS</paragraph-text></table-column><table-column><paragraph-text type="body">C-SETS FORMULA; LOCATION OF C-SETS RULES</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">#C12Na</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/10</class-ref> - <class-ref scheme="cpc">C12N15/1096</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">(<class-ref scheme="cpc">C12N</class-ref>, <class-ref scheme="cpc">C12Q</class-ref>), DNA or RNA isolation/preparation process and its essential technical features; See <class-ref scheme="cpc">C12N15/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">#C12Nb</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/64</class-ref> - <class-ref scheme="cpc">C12N15/66</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">(<class-ref scheme="cpc">C12N</class-ref>, <class-ref scheme="cpc">C12Q</class-ref>), method for preparing vectors and its essential technical features; See <class-ref scheme="cpc">C12N15/64</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">#C12Nc</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/00</class-ref> - <class-ref scheme="cpc">C12N2310/533</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/00</class-ref> - <class-ref scheme="cpc">C12N2330/51</class-ref></paragraph-text></table-column><table-column><paragraph-text type="body">(<class-ref scheme="cpc">C12N</class-ref>, <class-ref scheme="cpc">C12N</class-ref>) Structure of a nucleic acid; see <class-ref scheme="cpc">C12N2310/00</class-ref></paragraph-text></table-column></table-row></table><paragraph-text type="body">The specific C-Sets rule is located at only one place of the base symbol in the section &quot;Special rules of classification&quot; in the definition. If the C-Sets rule is applicable to all groups of a subclass, it is located at the subclass level only. If the same C-Sets rule is applicable to multiple groups or subgroups within the same subclass, the C-Sets rule is placed at the highest group or subgroup of the multiple groups.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Antisense</paragraph-text></table-column><table-column><paragraph-text type="body">DNA or RNA composed of the complementary sequence to the target DNA/RNA</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Aptamers</paragraph-text></table-column><table-column><paragraph-text type="body">Oligonucleotide molecules that bind a specific target molecule.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">CpG-motifs</paragraph-text></table-column><table-column><paragraph-text type="body">Cytosine-Phosphate-Guanine motifs; a cytosine is directly followed by a guanine in the DNA sequence; methylation of cytosine in CpG- motifs negatively regulates gene expression.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzyme</paragraph-text></table-column><table-column><paragraph-text type="body">Proteinaceous materials, which cause a chemical change in a starting material without being consumed in the reaction.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Genetic Engineering</paragraph-text></table-column><table-column><paragraph-text type="body">Technology used to alter the hereditary apparatus or gene structure of a living cell so that the cell can produce more or different chemicals, or perform completely new functions.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Germ cell</paragraph-text></table-column><table-column><paragraph-text type="body">Reproductive cells of the body, specifically, either egg or sperm cells.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Maintaining</paragraph-text></table-column><table-column><paragraph-text type="body">Supporting or sustaining growth or metabolic activity of microorganisms.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Microorganism</paragraph-text></table-column><table-column><paragraph-text type="body">Comprises single-celled organisms such as bacteria, actinomycetales or single-celled fungi, e.g. yeasts; for the purposes of classification, this term also includes viruses, human, animal or plant cells, protozoa, tissues and unicellular algae.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Multipotent stem cell</paragraph-text></table-column><table-column><paragraph-text type="body">A stem cell with the ability to give rise to multiple cell types belonging to one particular embryonic germ layer, the endoderm, the mesoderm or the ectoderm.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Mutation</paragraph-text></table-column><table-column><paragraph-text type="body">Any change that alters the sequence of bases along the DNA thereby changing the genetic material of a microorganism.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">NK cell</paragraph-text></table-column><table-column><paragraph-text type="body">Natural killer cell</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Non-coding nucleic acid sequence</paragraph-text></table-column><table-column><paragraph-text type="body">Nucleic acid sequence which does not contain instructions for making proteins.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Pluripotent stem cell</paragraph-text></table-column><table-column><paragraph-text type="body">A stem cell with the ability to differentiate into cells of at least two of the three embryonic germ layers, the endoderm, the mesoderm and the ectoderm.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preserving</paragraph-text></table-column><table-column><paragraph-text type="body">Rendering microorganisms reversibly dormant.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Proenzyme</paragraph-text></table-column><table-column><paragraph-text type="body">An enzyme precursor</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Progenitor cell</paragraph-text></table-column><table-column><paragraph-text type="body">A parent cell that gives rise to a distinct cell lineage by a series of cell divisions.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Recombinant DNA Technology</paragraph-text></table-column><table-column><paragraph-text type="body">Techniques for cutting apart and splicing together pieces of DNA from the same or different sources.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Single-cell protein</paragraph-text></table-column><table-column><paragraph-text type="body">Protein derived from microorganisms, usually bacteria or yeast, that are cultivated on a suitable medium and then harvested and processed for use as a food for livestock or humans. For example, blue-green bacterium Spirulina is processed and sold as a protein-rich health food.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Stem cell</paragraph-text></table-column><table-column><paragraph-text type="body">Cells capable of renewing themselves through mitotic cell division as well as differentiating into a diverse range of specialized cell types. The term covers adult stem cells as well as embryonic stem cells (ES) as derived from blastocysts.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Totipotent stem cell</paragraph-text></table-column><table-column><paragraph-text type="body">A stem cell with the ability to generate a whole organism autonomously; totipotent mammalian cells thus can differentiate into all three somatic lineages (endoderm or mesoderm or ectoderm), the germ line and extra embryonic tissues such as the placenta.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Vector</paragraph-text></table-column><table-column><paragraph-text type="body">A DNA sequence (e.g., plasmid, phage DNA) which may be employed to introduce a foreign gene into a host cell and is able to replicate autonomously in the host cell.</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2025-01-01"><classification-symbol scheme="cpc">C12N1/00</classification-symbol><definition-title>Microorganisms, e.g. protozoa; Compositions thereof  (medicinal preparations containing material from protozoa, bacteria or viruses <class-ref scheme="cpc">A61K35/66</class-ref>, from algae <class-ref scheme="cpc">A61K36/02</class-ref>, from fungi <class-ref scheme="cpc">A61K36/06</class-ref>; preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines, <class-ref scheme="cpc">A61K39/00</class-ref>); Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Main group <class-ref scheme="cpc">C12N1/00</class-ref> covers compositions comprising microorganisms, processes of treating microorganisms, and processes of culturing or growing of microorganisms.</paragraph-text><paragraph-text type="body">Subgroups <class-ref scheme="cpc">C12N1/10</class-ref>, <class-ref scheme="cpc">C12N1/12</class-ref>, <class-ref scheme="cpc">C12N1/14</class-ref>, <class-ref scheme="cpc">C12N1/16</class-ref>, <class-ref scheme="cpc">C12N1/18</class-ref>, <class-ref scheme="cpc">C12N1/20</class-ref> cover media compositions for a type of microorganism, compositions comprising a microorganism (with or without other compounds), processes of isolating, maintaining or propagating microorganisms which are specific for a class of microorganism.</paragraph-text><paragraph-text type="body">Subgroups <class-ref scheme="cpc">C12N1/105</class-ref>, <class-ref scheme="cpc">C12N1/125</class-ref>, <class-ref scheme="cpc">C12N1/145</class-ref>, <class-ref scheme="cpc">C12N1/165</class-ref>, <class-ref scheme="cpc">C12N1/185</class-ref>, or <class-ref scheme="cpc">C12N1/205</class-ref> covers a micro-organism per se which is a new natural isolate or a new mutant where the mutated gene is not known.</paragraph-text><paragraph-text type="body">Subgroup&#160;<class-ref scheme="cpc">C12N1/04</class-ref>&#160;covers methods of preserving or maintaining viable microorganisms, subgroups&#160;<class-ref scheme="cpc">C12N1/10</class-ref>, <class-ref scheme="cpc">C12N1/105</class-ref>, <class-ref scheme="cpc">C12N1/12</class-ref>, <class-ref scheme="cpc">C12N1/125</class-ref>, <class-ref scheme="cpc">C12N1/14</class-ref>, <class-ref scheme="cpc">C12N1/145</class-ref>, <class-ref scheme="cpc">C12N1/16</class-ref> - <class-ref scheme="cpc">C12N1/185</class-ref>, <class-ref scheme="cpc">C12N1/20</class-ref> and <class-ref scheme="cpc">C12N1/205</class-ref> cover compositions of microorganisms irrespective of whether they are viable or not.</paragraph-text><paragraph-text type="body">Subgroup <class-ref scheme="cpc">C12N1/36</class-ref> also covers attenuation of pathogens for vaccine preparation.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing material from microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K35/66</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing material from algae</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K36/02</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing material from fungi</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K36/06</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Animal cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N5/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Viruses</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N7/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Carrier-bound or immobilised microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N11/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Treatment of microorganisms with electrical or wave energy </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N13/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation of mutants without insertion of genetic material, screening processes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/01</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Algae other than microalgae</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01G33/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Biocides, pest repellants or attractants, plant growth regulators containing microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01N63/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Treating dough with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A21D8/04</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preservation of foods or foodstuffs, in general, using microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23B2/783</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fermentation of meat, fish </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23B4/12</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preservation of meat, sausages, fish with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23B4/20</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preservation of egg or egg products with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23B5/16</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preservation of fruit or vegetables by acid fermentation </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23B7/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preservation of edible seeds or cereals with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23B9/28</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fermented milk preparations, treatment using microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23C9/12</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Cream containing or treated by microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23C13/16</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Butter preparation, addition of microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23C15/123</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Butter having reduced fat content prepared by addition of microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23C15/165</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Buttermilk containing or treated with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23C17/02</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Making cheese curd with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23C19/032</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Treating cheese curd after whey separation with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23C19/061</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Whey preparations containing microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23C21/02</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Treating tea by fermentation with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23F3/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Tea extractions, extracts, with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23F3/166</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Coffee, removing unwanted substances, using microorganisms, preparations</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23F5/163</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Coffee, reducing or removing alkaloid content, using microorganisms, preparations</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23F5/204</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Extraction of coffee, coffee extracts, addition of or treatment with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23F5/246</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Treating cocoa by fermentation with microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23G1/02</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Cocoa products containing microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23G1/423</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Sweetmeats, confectionery or marzipan, containing microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23G3/364</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chewing gum containing microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23G4/12</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Frozen sweets, e.g. ice confectionery, ice-cream, containing microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23G9/36</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Obtaining protein compositions for feed-stuffs, from microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23J1/008</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">From cereals, wheat, bran, molasses by using microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23J1/12</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">From leguminous or other vegetable seeds from press-cake or oil-bearing seeds by treatment with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23J1/148</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">From yeasts </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23J1/18</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Animal feeding-stuffs, addition of microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23K10/16</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preservation of green fodder by ensilage using microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23K30/18</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Non-alcoholic beverages, fermented </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L2/382</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Non-alcoholic beverages, clarifying or fining using microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L2/84</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Food or foodstuffs, fermentation of farinaceous cereal or cereal material, addition of microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L7/104</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Food or foodstuffs, treatment of pulse, fermented pulses or legumes, removing undesirable substances, using microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L11/37</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Food or foodstuffs, treatment of pulse, fermented pulses or legumes, addition of microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L11/50</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Meat products, meat meal, addition of or treatment with microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L13/45</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Meat products, meat meal, with yeasts or fungi </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L13/46</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Meat products, meat meal, tenderised or flavoured meat pieces, addition of microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L13/74</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Egg products, addition of or treatment with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L15/25</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Food-from-the-sea products, fish, fish meal products, addition of or treatment with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L17/65</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Food consisting or nut meats or seeds, addition of or treatment with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L25/40</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Food or foodstuffs containing microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L29/065</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Food or foodstuffs, modifying nutritive quality, containing bacteria or derivatives, e.g. probiotics </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L33/135</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Food or foodstuffs, modifying nutritive quality, containing yeasts or derivatives </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23L33/14</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Tobacco products or substitutes, treatment with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A24B15/307</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Processes for making harmful chemical substances harmless or less harmful by biological methods using microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A62D3/02</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bioremediation, reclamation of contaminated soil microbiologically </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B09C1/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Biological treatment of water, wastewater or sewage </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C02F3/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Polypeptides, genes for polypeptides </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Compositions for enhanced recovery of hydrocarbons, using bacteria (microbial enhanced oil recovery) </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C09K8/582</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Refining of hydrocarbon oils by using microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C10G32/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Production of fats, pretreatment of raw materials by microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C11B1/025</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Detergent compositions containing microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C11D3/381</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Brewing of beer</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12C</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Wine, other alcoholic beverages, preparation thereof </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12G</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Vinegar, preparation thereof </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12J</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Apparatus for enzymology or microbiology</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12M</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fermentation and enzymatic processes for the preparation of compounds and compositions; including processes involving microorganisms of different genera in the same process, simultaneously </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P</class-ref>, <class-ref scheme="cpc">C12P29/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Measuring or testing processes involving microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Processes using microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12R</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Y</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Purification of sugar juices using microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C13B20/002</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Extraction of sucrose from molasses using microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C13B35/005</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Extraction of metal components from ores or concentrates with the aid of microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C22B3/18</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Obtaining uranium using microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C22B60/0256</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Directed molecular evolution of RNA, DNA, libraries, creating and screening processes (combinatorial chemistry) </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Libraries contained in or displayed by microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B</class-ref>, <class-ref scheme="cpc">C40B40/02</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Creation using whole viable microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B</class-ref>, <class-ref scheme="cpc">C40B50/06</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Libraries contained in or displayed by microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B40/02</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Methods of creating libraries using whole viable microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B50/06</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Treating fibres, threads, fabrics with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">D06M16/003</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Processes for obtaining cellulose by treatment of cellulose-containing material (waste paper, pulp) with microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">D21C5/005</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Treatment of cellulose-containing material with microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">D21C5/005</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Pulp or paper, addition of microorganisms thereto </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">D21H17/005</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Pulp, addition of microorganisms thereto</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">D21H17/005</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Investigating or analysing water using microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/1866</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassay, biospecific binding assay, for microorganisms </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/569</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Biochemical fuel cells in which microorganisms function as catalysts </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">H01M8/16</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Biofuels</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">Y02E50/10</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The last place rule is applicable, but all information should be given a group. For example, if both yeast and bacterial compositions are part of the invention in the application, then classify in both&#160;(<class-ref scheme="cpc">C12N1/16</class-ref> or <class-ref scheme="cpc">C12N1/165</class-ref>) and&#160;(<class-ref scheme="cpc">C12N1/20</class-ref> or <class-ref scheme="cpc">C12N1/205</class-ref>).</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Microorganism</paragraph-text></table-column><table-column><paragraph-text type="body">Includes bacteria and other generally unicellular organisms with dimensions beneath the limits of vision which can be propagated and manipulated in a laboratory, including unicellular fungi (including yeasts), microalgae, protozoa.</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2025-01-01"><classification-symbol scheme="cpc">C12N1/04</classification-symbol><definition-title>Preserving or maintaining viable microorganisms  (immobilised microorganisms <class-ref scheme="cpc">C12N11/00</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods of preserving or maintaining viable microorganisms which include protozoa, unicellular algae, fungi, bacteria, archaea, spores, viruses or bacteriophages.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Subgroups&#160;<class-ref scheme="cpc">C12N1/10</class-ref> - <class-ref scheme="cpc">C12N1/205</class-ref>&#160;cover compositions of microorganisms irrespective of whether they are viable or not.</paragraph-text><paragraph-text type="body">Natural isolates are classified in <class-ref scheme="cpc">C12R</class-ref>.</paragraph-text><paragraph-text type="body">Preservation of excised body parts of humans or animals is classified in <class-ref scheme="cpc">A01N1/10</class-ref>.</paragraph-text><paragraph-text type="body">Preservation of animal or human cells or tissues is classified in <class-ref scheme="cpc">C12N5/52</class-ref>, <class-ref scheme="cpc">C12N5/54</class-ref> or <class-ref scheme="cpc">C12N5/56</class-ref>.</paragraph-text></section-body></relationship><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Immobilized microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N11/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item date-revised="2021-05-01"><classification-symbol scheme="cpc">C12N1/10</classification-symbol><definition-title>Protozoa; Culture media therefor</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Media compositions for protozoa, compositions comprising protozoa (with or without other compounds), processes of isolating, maintaining or propagating protozoa.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Microorganisms expressing a defined gene (if an operon is expressed)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/52</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Mutant microorganisms in which the mutation is defined (according to the defined mutation)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C12Y</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Microorganisms expressing a defined gene (according to the defined gene) </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C12Y</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Processes for the preparation of a compound or substance using a microorganism </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Naturally isolated protozoa or mutant protozoa in which the mutation is undefined or cannot be defined are covered by <class-ref scheme="cpc">C12N1/105</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2021-05-01"><classification-symbol scheme="cpc">C12N1/12</classification-symbol><definition-title>Unicellular algae; Culture media therefor  (as new plants <class-ref scheme="cpc">A01H13/00</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Media compositions for unicellular algae, compositions comprising unicellular microalgae (with or without other compounds), processes of isolating, maintaining or propagating unicellular microalgae.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Algae as new plants</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01H13/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body"> Naturally isolated microorganisms, or mutant microorganisms in which the mutation is undefined or cannot be defined, if an adapted or attenuated microorganism is obtained</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N1/36</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Microorganisms expressing a defined gene (if an operon is expressed)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/52</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Mutant microorganisms in which the mutation is defined (according to the defined mutation)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C12Y</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Microorganisms expressing a defined gene (according to the defined gene) </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C12Y</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Processes for the preparation of a compound or substance using a microorganism</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Looping references between <class-ref scheme="cpc">C12N1/12</class-ref> and <class-ref scheme="cpc">A01H13/00</class-ref> have been identified. Until this inconsistency is resolved in IPC, the current classification practice in CPC is as follows:</paragraph-text><paragraph-text type="body">The reference should stay in the title of CPC until the correction/change is made in IPC. </paragraph-text><paragraph-text type="body">Naturally isolated unicellular algae or mutant unicellular algae in which the mutation is undefined or cannot be defined are covered by <class-ref scheme="cpc">C12N1/125</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2021-05-01"><classification-symbol scheme="cpc">C12N1/14</classification-symbol><definition-title>Fungi  (culture of mushrooms <class-ref scheme="cpc">A01G18/00</class-ref>; as new plants <class-ref scheme="cpc">A01H15/00</class-ref>); Culture media therefor</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Subgroup <class-ref scheme="cpc">C12N1/14</class-ref> (and lower groups <class-ref scheme="cpc">C12N1/16</class-ref> and <class-ref scheme="cpc">C12N1/18</class-ref>) covers media compositions for fungi (yeasts), compositions comprising fungi (yeasts) (with or without other compounds), processes of isolating, maintaining or propagating fungi (yeasts).</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Culture of Mushrooms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01G18/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fungi as new plants </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01H15/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Naturally isolated micro-organisms, or mutant micro-organisms in which the mutation is undefined or cannot be defined, if an adapted or attenuated micro-organism is obtained</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N1/36</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Micro-organisms expressing a defined gene (if an operon is expressed)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/52</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Cosmetic or medicinal compositions or preparations comprising a micro-organism </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K</class-ref>, <class-ref scheme="cpc">A61K35/66</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Mutant micro-organisms in which the mutation is defined (according to the defined mutation)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C12Y</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Micro-organisms expressing a defined gene (according to the defined gene) </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C12Y</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Processes for the preparation of a compound or substance using a micro-organism </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Looping references between <class-ref scheme="cpc">C12N1/14</class-ref> and <class-ref scheme="cpc">A01H15/00</class-ref> have been identified. Until this inconsistency is resolved in IPC, the current classification practice in CPC is as follows:</paragraph-text><paragraph-text type="body">The reference should stay in the title of CPC until the correction/change is made in IPC. </paragraph-text><paragraph-text type="body">Naturally isolated fungi, yeast or Saccharomyces, or mutant fungi, yeast or Saccharomyces in which the mutation is undefined or cannot be defined are covered by <class-ref scheme="cpc">C12N1/145</class-ref>, <class-ref scheme="cpc">C12N1/165</class-ref> and <class-ref scheme="cpc">C12N1/185</class-ref> and the appropriate <class-ref scheme="cpc">C12R</class-ref> subgroup.</paragraph-text><paragraph-text type="body">If the invention pertains to the attenuation of fungi, classification in <class-ref scheme="cpc">C12N1/36</class-ref> should also be considered.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2021-05-01"><classification-symbol scheme="cpc">C12N1/20</classification-symbol><definition-title>Bacteria; Culture media therefor</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Media compositions for bacteria, compositions comprising bacteria (with or without other compounds), processes of isolating, maintaining or propagating bacteria.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Microorganisms expressing a defined gene (if an operon is expressed)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/52</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Mutant microorganisms in which the mutation is defined (according to the defined mutation)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C12Y</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Microorganisms expressing a defined gene (according to the defined gene) </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C12Y</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Processes for the preparation of a compound or substance using a microorganism </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Naturally isolated bacteria, or mutant bacteria in which the mutation is undefined or cannot be defined are covered by <class-ref scheme="cpc">C12N1/205</class-ref> and the appropriate <class-ref scheme="cpc">C12R</class-ref> subgroup.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2017-08-01"><classification-symbol scheme="cpc">C12N3/00</classification-symbol><definition-title>Spore forming or isolating processes</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Processes for spore formation and for isolation of spores.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Spores, spore-containing compositions or processes using spores.Spores, compositions containing spores, processes using spores can be classified according to microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N1/00</class-ref>, <class-ref scheme="cpc">C12P</class-ref>, <class-ref scheme="cpc">C12R</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body"> Processes using microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12R</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Spore</paragraph-text></table-column><table-column><paragraph-text type="body">Reproductive structure that is adapted for dispersal and surviving for extended periods of time, e.g. in unfavorable conditions. Spores form part of the life cycles of many microorganisms such as bacteria, microalgae, fungi and some protozoa.</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms><synonyms-keywords><section-title>Synonyms and Keywords</section-title><abbreviations>
<paragraph-text type="preamble">In patent documents, the following abbreviations are often used:</paragraph-text>
<table>
<table-row><table-column><paragraph-text type="body">Spore </paragraph-text></table-column><table-column><paragraph-text type="body">Endospore, exospore, myxospore, cyst</paragraph-text></table-column></table-row></table>
</abbreviations></synonyms-keywords></definition-item>
<definition-item date-revised="2025-01-01"><classification-symbol scheme="cpc">C12N5/00</classification-symbol><definition-title>Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor;  (plant reproduction by tissue culture techniques <class-ref scheme="cpc">A01H4/00</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Animal cells, animal cell culture, differentiation in vitro are to be classified in&#160;<class-ref scheme="cpc">C12N5/00</class-ref>, provided that such products and processes are characterized and exemplified in the application. A cell which is merely claimed without real and exemplified provision thereof shall not be classified in&#160;<class-ref scheme="cpc">C12N5/00</class-ref>. This is the case - for example - where the examples only relate to differentiation of a stem cell to pancreatic cells, but where differentiation to hepatocytes or nerve cells is claimed. Then, only the differentiated pancreatic cells are classified. The other cells are not classified at all.</paragraph-text></list-item><list-item><paragraph-text type="body">Orthogonal Indexing Codes <class-ref scheme="cpc">C12N2500/00</class-ref> - <class-ref scheme="cpc">C12N2539/10</class-ref> are compulsory when classifying in this place. This relates to any specific and exemplified component of cell culture medium, active agent used in cell culture process, co-culture with or conditioned medium produced by, use of differentiation from one lineage to another or from pluripotent cells, use of cells in diagnostic, methods for the dissociation of cells, genetically modified cells, cells related to new breeds of animals, culture process characterised by the use of forces and support or coating for cells culture characterised by material, topography, treatment or properties. Any such additional information which is claimed but not exemplified is however not to be classified.</paragraph-text></list-item><list-item><paragraph-text type="body">Cells or tissues in medicinal preparations or for medical uses are classified in&#160;<class-ref scheme="cpc">A61K35/12</class-ref>&#160;-&#160;<class-ref scheme="cpc">A61K35/65</class-ref>&#160;irrespective of genetic modification or culture steps. Cells that are medically used after a relevant in vitro culturing step are classified in&#160;<class-ref scheme="cpc">A61K35/00</class-ref>&#160;and&#160;<class-ref scheme="cpc">C12N5/00</class-ref>.</paragraph-text></list-item></list><paragraph-text type="subheading">Further details of subgroups</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/00</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">The highest rank head group is to be used only in desperate cases, for documents which do not fit elsewhere, e.g. culture processes characterised by temperature</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0006</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">By exception to the dividing line general <class-ref scheme="cpc">C12N5/00</class-ref> to the specific <class-ref scheme="cpc">C12N5/06</class-ref>, documents describing the modification of membranes of a specific cell type are classified both in&#160;<class-ref scheme="cpc">C12N5/0006</class-ref>&#160;and&#160;<class-ref scheme="cpc">C12N5/06</class-ref>&#160;and subgroups.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0012</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Only generic encapsulation here: Encapsulation of a specific cell type is&#160;<class-ref scheme="cpc">C12N5/06</class-ref>&#160;(and subgroups),&#160;<class-ref scheme="cpc">C12N2533/00</class-ref>&#160;Orthogonal Indexing codes may be used for the capsule material. Classifying the document in&#160;<class-ref scheme="cpc">A61L27/00</class-ref>&#160;and/or&#160;<class-ref scheme="cpc">A61K47/00</class-ref>&#160;should be considered. Encapsulation in fermenters is&#160;<class-ref scheme="cpc">C12N13/00</class-ref>. Note that encapsulated hepatocytes and pancreatic cells have specific subgroups:&#160;<class-ref scheme="cpc">C12N5/0671</class-ref>&#160;and&#160;<class-ref scheme="cpc">C12N5/0677</class-ref>.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0018</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Generic media for potentially any type of cells. Culture processes using a particular agent are treated as a culture medium containing this agent (e.g. use of propranolol in cell culture:&#160;<class-ref scheme="cpc">C12N5/0018</class-ref>, <class-ref scheme="cpc">C12N2501/81</class-ref>). All documents should have at least one Orthogonal Indexing code from the range&#160;<class-ref scheme="cpc">C12N2500/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12N2502/00</class-ref>, and possibly many of them. Examples using CHO, 3T3, BHK or other common cell types should be regarded as generic disclosure and classified under&#160;<class-ref scheme="cpc">C12N5/00</class-ref>&#160;rather than under&#160;<class-ref scheme="cpc">C12N5/06</class-ref>.</paragraph-text><paragraph-text type="body">When a new medium is fully disclosed, most if not all&#160;<class-ref scheme="cpc">C12N2500/00</class-ref>&#160;Orthogonal Indexing codes potentially apply; codes should be given for any useful information, i.e. any specific component with a specific concentration range (e.g. Ala 20 &#181;, Pro 10 &#181; &#8230; is indexed&#160;<class-ref scheme="cpc">C12N2500/32</class-ref>; reference to a standard composition of essential amino-acids as one component need not be indexed)&#8212;which can mean that many codes are actually given, but this appears to be the best way to retrieve reasonably quickly a document with a medium comprising, e.g., 10-100 nM Cu<sup>2+</sup>&#160;or 20-75 &#181; Glu. It may not be necessary to index the most common additives (e.g. glutamine) and no code is foreseen for antibiotics, as these appear to be invariably present.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0031</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Note that serum-free media for specific cell types are&#160;<class-ref scheme="cpc">C12N5/06</class-ref>&#160;(and subgroups),&#160;<class-ref scheme="cpc">C12N2500/99</class-ref>.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0081</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">By &quot;negative selection&quot;, it is meant that the document defines what is to be rejected but does not define in any positive manner what is to be retained. The combination of negative and positive markers is regarded as positive selection, and should normally allow to assign a specific type to the cells, and to classify in&#160;<class-ref scheme="cpc">C12N5/06</class-ref>&#160;(and subgroups). In practice,&#160;<class-ref scheme="cpc">C12N5/0087</class-ref>&#160;and&#160;<class-ref scheme="cpc">C12N5/0093</class-ref>&#160;deal with purging blood or bone marrow (but also, rarely, of other tissues) from, respectively, immune cells and tumour cells before transplantation;&#160;<class-ref scheme="cpc">C12N5/0081</class-ref>&#160;is thus very rarely used.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0068</class-ref>, <class-ref scheme="cpc">C12N5/0075</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Documents should have at least one&#160;<class-ref scheme="cpc">C12N2533/00</class-ref>&#160;Orthogonal Indexing Code. Supports for specific cell types are&#160;<class-ref scheme="cpc">C12N5/06</class-ref>&#160;(and subgroups),&#160;<class-ref scheme="cpc">C12N2531/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12N2539/00</class-ref>.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/06</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Classification is made in the appropriate group below&#160;<class-ref scheme="cpc">C12N5/06</class-ref>; group&#160;<class-ref scheme="cpc">C12N5/06</class-ref>&#160;implies that the teachings apply only to specific cells and it should always be possible to know whether the cells derive from vertebrates or invertebrates.</paragraph-text><paragraph-text type="body">General Considerations:</paragraph-text><paragraph-text type="body">The scope of any sub-group comprises the cells of the title, any tissue explant essentially consisting of these cells (e.g. skin = keratinocytes =&#160;<class-ref scheme="cpc">C12N5/0629</class-ref>), processes for isolating these cells (e.g. the definition of a set of markers to isolate a specific cell by FACS, but a document dealing with a specific antibody for one single marker can be classified solely in&#160;<class-ref scheme="cpc">C07K16/00</class-ref>), processes for preparing these cells (culture, differentiation), culture media and/supports specifically adapted for these cells and medical uses of these cells (as far as the nature of the cells is known and is relevant; e.g. medical composition of cultivated pancreatic cells&#160;<class-ref scheme="cpc">C12N5/0676</class-ref>, <class-ref scheme="cpc">A61K35/12</class-ref>, &quot;low-tech&quot; composition of animal tissue extracts&#160;<class-ref scheme="cpc">A61K35/00</class-ref>&#160;and subgroups, photochemically-treated blood&#160;<class-ref scheme="cpc">A61K41/0057</class-ref>, <class-ref scheme="cpc">A61K35/14</class-ref>).</paragraph-text><paragraph-text type="body">Controlled language: Title note of&#160;<class-ref scheme="cpc">C12N5/06</class-ref>: In this group, the following words are used with the meanings indicated:</paragraph-text><list><list-item><paragraph-text type="body">a &quot;totipotent&quot; cell can differentiate into all somatic lineages (ectoderm, mesoderm, endoderm), the germ line and extra embryonic tissues such as the placenta;</paragraph-text></list-item><list-item><paragraph-text type="body">a &quot;pluripotent&quot; cell is a somatic stem cell which can differentiate into cells of at least two of the three somatic lineages (ectoderm, mesoderm, endoderm);</paragraph-text></list-item><list-item><paragraph-text type="body">a &quot;multipotent&quot; cell is restricted to one lineage.</paragraph-text></list-item><list-item><paragraph-text type="body">&quot;Progenitor&quot; and &quot;precursor&quot; cells are further restricted within the lineage. If not explicitly foreseen, totipotent cells are classified with pluripotent cells. Multipotent cells should not be classified with pluripotent cells.</paragraph-text></list-item></list><paragraph-text type="body">This has been adopted to clarify classification practice with respect to the use of the words &quot;pluri-&quot; and &quot;multipotent.&quot; Under this definition, totipotent cells need to be able to generate placenta and amnion, i.e. only the zygote, blastula and morula cells strictly qualify; applicants tend to use the term more liberally &#8230; Conversely, the archetypal example of an adult pluripotent cell in the sense of&#160;<class-ref scheme="cpc">C12N5/0607</class-ref>, has been named &quot;Multipotent Adult Stem (Progenitor) Cell&quot; (MASC, MAPC) by its discoverers, which is too restrictive in view of our definitions.</paragraph-text><paragraph-text type="body">Immediate precursors:</paragraph-text><paragraph-text type="body">&quot;Four dot&quot; stem/precursor/progenitor groups usually cover (multipotent) stem cells as well as (restricted) precursors and committed progenitors, but there are two important exceptions with respect to the latter: myoblasts go with myotubes in <class-ref scheme="cpc">C12N5/0658</class-ref> (since myotubes do not proliferate, culture can only be directed to their precursors). In the blood/immune hierarchy&#160;<class-ref scheme="cpc">C12N5/0634</class-ref>, immediate, committed, precursors are classified with their progeny;&#160;<class-ref scheme="cpc">C12N5/0647</class-ref>&#160;is reserved for stem cells and multi-lineage progenitors.</paragraph-text><paragraph-text type="body">Sub-headgroups&#160;<class-ref scheme="cpc">C12N5/0603</class-ref>, <class-ref scheme="cpc">C12N5/0608</class-ref>, <class-ref scheme="cpc">C12N5/0613</class-ref>, <class-ref scheme="cpc">C12N5/0618</class-ref>, etc vs. specific subgroups&#160;<class-ref scheme="cpc">C12N5/0604</class-ref>, <class-ref scheme="cpc">C12N5/0605</class-ref>, <class-ref scheme="cpc">C12N5/0606</class-ref>, <class-ref scheme="cpc">C12N5/0608</class-ref>:</paragraph-text><paragraph-text type="body">The &quot;three dot&quot; (sub)headgroups are used for two different purposes:</paragraph-text><list><list-item><paragraph-text type="body">for cells whose precise type is not (yet) foreseen in the scheme,</paragraph-text></list-item><list-item><paragraph-text type="body">as a broad indication of end product where the examples do not provide enough evidence as to the result of a differentiation process</paragraph-text></list-item></list><paragraph-text type="body">E.g. a document pertaining to neural differentiation of BM-MSC is&#160;<class-ref scheme="cpc">C12N5/0618</class-ref>, <class-ref scheme="cpc">C12N2506/1353</class-ref>&#160;while a document pertaining to neuronal differentiation of BM- MSC, with detailed, extensive, evidence as to the neuronal phenotype is&#160;<class-ref scheme="cpc">C12N5/0619</class-ref>, <class-ref scheme="cpc">C12N2506/1353</class-ref>. In the intermediate situation where a document claims neuronal differentiation with only limited evidence (e.g. one or two markers), it is preferred to use the headgroup&#160;<class-ref scheme="cpc">C12N5/0618</class-ref>, especially if the document additionally provides examples of oligodendrocyte/glial differentiation at the same poor level of evidence.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0602</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">The head group should be used only for specific vertebrate cells which do not fit elsewhere in the scheme. Generic disclosure for vertebrate cells is&#160;<class-ref scheme="cpc">C12N5/00</class-ref>&#160;(and subgroups).</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0603</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">This is actually &quot;embryonic or foetal cells and tissues&quot;, but interpreted in a very restricted sense to encompass only cells that are solely embryonic and/or foetal; embryonic/foetal cells of recognisable type which are also present in an adult are classified as adult cells. &quot;Rejuvenated&quot; cells claimed to have been brought back to pluripotency or cells described by an applicant as &quot;ES-like&quot; do not qualify for&#160;<class-ref scheme="cpc">C12N5/0606</class-ref>: These cells do not actually originate from an embryo or foetus, see&#160;<class-ref scheme="cpc">C12N5/0607</class-ref>(A). In practice,&#160;<class-ref scheme="cpc">C12N5/0603</class-ref>&#160;itself only contains embryoid bodies and cells being in an intermediate stage of differentiation between pluripotent cells (ES) and &quot;adult&quot; (typable) tissue; e.g. &quot;definitive endoderm&quot; cells&#160;<class-ref scheme="cpc">C12N5/0603</class-ref>&#160;(exists only in embryo), pancreatic cells&#160;<class-ref scheme="cpc">C12N5/0676</class-ref>&#160;(adult). Embryonic germ (EG) cells, which can be regarded as an equivalent for ES, are&#160;<class-ref scheme="cpc">C12N5/0611</class-ref>, but embryonic carcinoma (EC) cells are classified in&#160;<class-ref scheme="cpc">C12N5/0606</class-ref>&#160;as far as they are used as a model for ES (now that human ES have been isolated, EC technology appears to be obsolete).</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0607</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Pluripotent adult stem cells are still a controversial and largely speculative topic. Extreme care must be exercised when allocating this class: to qualify, a cell must have demonstrated pluripotency (note that the corresponding examples of differentiation into at least two distinct lineages are not to be indexed) and must not belong to any other subgroup of the scheme.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0696</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">This covers all kinds of (demonstrated) &quot;rejuvenated&quot; cells or induced pluripotent stem cells (iPS). The rejuvenation method/agents are to classified appropriately (<class-ref scheme="cpc">C12N2510/00</class-ref>&#160;and&#160;<class-ref scheme="cpc">C12N2501/60</class-ref>&#160;for typical iPS obtained by forced expression of Oct-3/4, Sox-2, Klf4, Nanog, cMyc&#8230;;&#160;<class-ref scheme="cpc">C12N2501/00</class-ref>, <class-ref scheme="cpc">C12N2500/00</class-ref>, <class-ref scheme="cpc">C12N2502/00</class-ref>&#160;as appropriate for chemical agents). Detailed aspects regarding the construction of a suitable expression vector are to be classified in&#160;<class-ref scheme="cpc">C12N15/00</class-ref>.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0608</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">The head group is to remain empty until a third mammalian sex is discovered or engineered. The few documents dealing both with oocytes and spermatozoa are classified in both subgroups&#160;<class-ref scheme="cpc">C12N5/0609</class-ref>&#160;and&#160;<class-ref scheme="cpc">C12N5/061</class-ref>.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0658</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">For practical reasons, precursors (myoblasts) have been grouped with their progeny (myotubes); as a result, only few documents remain in&#160;<class-ref scheme="cpc">C12N5/0659</class-ref>&#160;(satellite cells).</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0634</class-ref>, <class-ref scheme="cpc">C12N5/0636</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12N5/064</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Owing to the complexity of the lineage, committed precursors are grouped with their immediate progeny: e.g. pre-T cells go with T cells in&#160;<class-ref scheme="cpc">C12N5/0636</class-ref>; lymphoid stem cells, which can give rise either to B or T, remain in&#160;<class-ref scheme="cpc">C12N5/0647</class-ref>.</paragraph-text><paragraph-text type="body">Vaccines: Immunogenic preparations (e.g. stimulated T cells, antigen-loaded dendritic cells or microphages) are classified in&#160;<class-ref scheme="cpc">A61K39/00</class-ref>&#160;and subgroups according to the antigen with the appropriate&#160;<class-ref scheme="cpc">A61K2039/51</class-ref>&#160;-&#160;<class-ref scheme="cpc">A61K2039/892</class-ref>&#160;Indexing Code(s).</paragraph-text><paragraph-text type="body">Immunotherapy: Cells classified in&#160;<class-ref scheme="cpc">C12N5/0634</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12N5/0639</class-ref>&#160;are additionally classified in&#160;<class-ref scheme="cpc">A61K40/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">A61K40/50</class-ref>&#160;with Orthogonal indexing codes&#160;<class-ref scheme="cpc">A61K2239/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">A61K2239/59</class-ref>, when the cells are modified for immunotherapy (e.g. CAR-T cells).</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0629</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0629</class-ref>&#160;contains purified keratinocytes and whole skin biopsies, assigned to what is regarded as the most relevant cell type, but artificially reconstructed skin is&#160;<class-ref scheme="cpc">C12N5/0698</class-ref>.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0671</class-ref>, <class-ref scheme="cpc">C12N5/0677</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Encapsulation is assimilated to 3D culture.&#160;<class-ref scheme="cpc">C12N2533/00</class-ref>&#160;Orthogonal indexing codes may apply to the capsule material.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0691</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">For practical reasons, this group contains isolated vascular smooth muscle cells (not&#160;<class-ref scheme="cpc">C12N5/0661</class-ref>) as well as elaborated three-dimensional constructs comprising multiple types (e.g. vascular endothelium&#160;<class-ref scheme="cpc">C12N5/069</class-ref>, fibroblasts&#160;<class-ref scheme="cpc">C12N5/0656</class-ref>); in the latter case, the further cell types may be indexed with&#160;<class-ref scheme="cpc">C12N2502/00</class-ref>&#160;Orthogonal Indexing codes as in&#160;<class-ref scheme="cpc">C12N5/0697</class-ref>.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0692</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Haemangioblasts, which are precursors for both the haematopoietic and the vascular endothelial lineages, always get a double class:&#160;<class-ref scheme="cpc">C12N5/0647</class-ref>, <class-ref scheme="cpc">C12N5/0692</class-ref>.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0693</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Tumour cells considered for themselves (i.e. as tumours) are classified here, but tumour cells used as convenient immortalised equivalents/models of their untransformed counterparts are classified as normal cells: e.g. embryonic carcinoma&#160;<class-ref scheme="cpc">C12N5/0606</class-ref>; medium specially adapted for hepatomas&#160;<class-ref scheme="cpc">C12N5/067</class-ref>, <class-ref scheme="cpc">C12N2500/00</class-ref>, <class-ref scheme="cpc">C12N2501/00</class-ref>, <class-ref scheme="cpc">C12N2502/00</class-ref>, <class-ref scheme="cpc">C12N2503/00</class-ref>, <class-ref scheme="cpc">C12N2506/00</class-ref>, <class-ref scheme="cpc">C12N2509/00</class-ref>.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0694</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Myeloma cell lines for use in the making of hybridomas are directly classified in&#160;<class-ref scheme="cpc">C12N5/163</class-ref>, with their application, rather than as&#160;<class-ref scheme="cpc">C12N5/0694</class-ref>.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0697</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">&quot;Tissue equivalent&quot; is to be construed broadly as any in vitro construct associating different cell types to achieve one function; the precise structure or function of an actual tissue need not be achieved but it must be an artificial construct, not an actual tissue explant (<class-ref scheme="cpc">C12N5/0602</class-ref>&#160;and subgroups, according to the source or dominant cell type), and no single cell type must be responsible for the desired effect, as is the case for a typical co-culture. Examples: model of neuromuscular junction where a neuron commands a muscle cell&#160;<class-ref scheme="cpc">C12N5/0697</class-ref>, <class-ref scheme="cpc">C12N2502/081</class-ref>, <class-ref scheme="cpc">C12N2502/1335</class-ref>; testicular prosthesis consisting of chondrocytes (for shape) and of Sertoli cells (for hormonal function),&#160;<class-ref scheme="cpc">C12N5/0697</class-ref>, <class-ref scheme="cpc">C12N2502/1317</class-ref>, <class-ref scheme="cpc">C12N2502/24</class-ref>; but embryonic stem cells on a feeder layer of embryonic fibroblast&#160;<class-ref scheme="cpc">C12N5/0606</class-ref>, <class-ref scheme="cpc">C12N2502/13</class-ref>.&#160;<class-ref scheme="cpc">C12N2502/00</class-ref>&#160;codes are used to index all cell types, including accessory ones (e.g. vascular cells or tumour cells added in some illustrated embodiments to study vascular or tumour growth inside a tissue).</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/10</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Not to be used. Genetic engineering itself is classified in&#160;<class-ref scheme="cpc">C12N15/00</class-ref>; cells modified for a particular application (e.g. recombinant expression, promoter-reporter constructs for testing) are classified with the application (<class-ref scheme="cpc">C07K14/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">C07K14/16</class-ref>, <class-ref scheme="cpc">G01N33/00</class-ref>, <class-ref scheme="cpc">C12Q1/00</class-ref>). Classification in&#160;<class-ref scheme="cpc">C12N5/00</class-ref>&#160;is done only if there is actual interest in the cell itself; e.g. transfecting pdx1 in MSC to yield insulin-secreting cells (assimilated to pancreatic delta cells, according to the sought therapeutic effect, even though full differentiation and full functionality may not be achieved)&#160;<class-ref scheme="cpc">C12N5/0676</class-ref>, <class-ref scheme="cpc">C12N2506/1353</class-ref>, <class-ref scheme="cpc">C12N2510/00</class-ref>.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/12</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Has only been used for extremely rare cases of generic fused cell technology applicable equally to animal, vegetal, fungal (yeast) or bacterial cells.</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N5/16</class-ref>:</paragraph-text></list-item></list><paragraph-text type="body">Fusion partners are not indexed.&#160;<class-ref scheme="cpc">C12N5/163</class-ref>&#160;covers also cell lines to be used as fusion partners, but not specific hybridomas producing a specific antibody.</paragraph-text><paragraph-text type="body">Some &quot;rejuvenated&quot; cells prepared by introducing &quot;young&quot; cytoplasm into &quot;old&quot; cells, or even by transferring &quot;old&quot; nuclei into enucleated &quot;young&quot; cells&quot; have been assimilated to fused cells and classified here. See also Orthogonal Indexing code&#160;<class-ref scheme="cpc">C12N2506/00</class-ref>. Note that nuclear transfer in itself is&#160;<class-ref scheme="cpc">C12N15/873</class-ref>&#160;and circulation is warranted. Proper cloning is not classified here.</paragraph-text><paragraph-text type="body">Immunotherapy: Cells classified in <class-ref scheme="cpc">C12N5/0634</class-ref> - <class-ref scheme="cpc">C12N5/0639</class-ref> are additionally classified in <class-ref scheme="cpc">A61K40/00</class-ref> - <class-ref scheme="cpc">A61K40/50</class-ref> with indexing codes <class-ref scheme="cpc">A61K2239/00</class-ref> - <class-ref scheme="cpc">A61K2239/59</class-ref>, when the cells are modified for immunotherapy (e.g. CAR-T cells).</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Plants reproduction by tissue culture techniques </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01H4/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Plants </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0025</class-ref>, <class-ref scheme="cpc">C12N5/04</class-ref>, <class-ref scheme="cpc">C12N5/14</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Mutation or genetic engineering; Use of hosts therefore</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Use of cells in vaccines or immunological preparations</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Gene therapy</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Recombinant expression of proteins</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C07K16/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Apparatus for cell culture</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12M</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Apparatus for cell purification</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Screening and/or testing using cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/00</class-ref>, <class-ref scheme="cpc">C12Q1/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Classification Policy</paragraph-text><paragraph-text type="body">Considering that:</paragraph-text><list><list-item><paragraph-text type="body">Documentation is a search tool;</paragraph-text></list-item><list-item><paragraph-text type="body">Laundry lists of further possible agents or appli&#8203;ca&#8203;tions, wishes (mere &quot;hope to succeed&quot;) and plans for future exten&#8203;sive research are of little interest;</paragraph-text></list-item><list-item><paragraph-text type="body">If it is useful to cite a formal X document, such wish lists can easily be retrieved by full text search while actual technical content cannot easily be extracted from patent databases, due to the overall poor quality of abstracts and the noise generated in full text mode by the laundry lists; classification is based, and solely based, on what has actually been done, i.e. classification is based on the actual examples and not on the claims.</paragraph-text></list-item></list><paragraph-text type="body">All relevant aspects of the examples, including unclaimed aspects, are classified as allowed by the scheme at the most specific place; the wording of the claims, e.g. with respect to further appli&#8203;ca&#8203;tions or possible generalisation, need not be considered and shall not be classified in the absence of actual support in the examples. The &quot;last place rule&quot; is not used; multiple symbols may be given as needed.</paragraph-text><paragraph-text type="body">Irrelevant aspects, which are not classified are those upstream and/or downstream the invention (or &quot;contribution to the art&quot;):</paragraph-text><list><list-item><paragraph-text type="body">Upstream. If the invention is directed to the growth or differentiation of cells, the process used to obtain and purify the starting cell material;</paragraph-text></list-item><list-item><paragraph-text type="body">Downstream. Further testing with or about the grown or differentiated cells, e.g. checking for stemness by causing cells to differentiate, assessing the function of the resulting cells, in vitro testing for phar&#8203;ma&#8203;ceuticals, etc.</paragraph-text></list-item></list><paragraph-text type="body">A document whose examples are solely directed to testing in cells is not to be clas&#8203;si&#8203;fied at all in <class-ref scheme="cpc">C12N5/00</class-ref> but only either in <class-ref scheme="cpc">G01N33/00</class-ref> or <class-ref scheme="cpc">C12Q1/00</class-ref> (if emphasis is on the testing itself) or in <class-ref scheme="cpc">A61K31/00</class-ref> - <class-ref scheme="cpc">A61K38/00</class-ref> (if the intent lies with in vivo therapy after pre-clinical tests).</paragraph-text><paragraph-text type="body">Non-patent literature is not classified, owing to its sheer abundance and to the quality of dedicated databases.</paragraph-text><paragraph-text type="body">Some Principles and Practices</paragraph-text><list><list-item><paragraph-text type="body">Generic vs. Specific: <class-ref scheme="cpc">C12N5/00</class-ref> and subgroups are used for general aspects, e.g. &quot;universal&quot; culture media or supports, while subgroups of <class-ref scheme="cpc">C12N5/06</class-ref> are used for cell-type specific aspects; thus, classification is gene&#8203;rally under <class-ref scheme="cpc">C12N5/06</class-ref>, with the appropriate deep Indexing symbol <class-ref scheme="cpc">C12N5/00</class-ref>. Examples using com&#8203;mon cell types such as 3T3, CHO, BHK (&quot;eucaryotic equivalent of E. coli&quot;) are classified as generic.</paragraph-text></list-item><list-item><paragraph-text type="body">Stem vs. Differentiated Cells: Classification is based on the end product as available to the skilled person. Documents pertaining to the purification of stem cells are classified as the stem cells; possible examples illustrating the potency of these cells to differentiate are not classified. Documents pertaining to the diffe&#8203;ren&#8203;tiation of stem cells are classified as the end product in the lower subgroups of <class-ref scheme="cpc">C12N5/0602</class-ref>, with all applicable symbols <class-ref scheme="cpc">C12N2500/00</class-ref> - <class-ref scheme="cpc">C12N2502/00</class-ref> and possibly <class-ref scheme="cpc">C12N2506/00</class-ref>; no symbol is given for the starting material, unless the docu&#8203;ment also discloses new protocols for its purification and/or maintenance. Docu&#8203;ments pertaining to in vivo differentiation of stem cells are classified as the available product, i.e. as (a composition of) stem cells <class-ref scheme="cpc">C12N5/0606</class-ref>, <class-ref scheme="cpc">C12N5/0611</class-ref>, <class-ref scheme="cpc">C12N5/0623</class-ref>, <class-ref scheme="cpc">C12N5/0647</class-ref>, <class-ref scheme="cpc">C12N5/0662</class-ref> - <class-ref scheme="cpc">C12N5/0668</class-ref> , <class-ref scheme="cpc">C12N5/0672</class-ref>, <class-ref scheme="cpc">C12N5/0678</class-ref>, <class-ref scheme="cpc">C12N5/068</class-ref>, <class-ref scheme="cpc">C12N5/0687</class-ref>, <class-ref scheme="cpc">C12N5/0689</class-ref>, <class-ref scheme="cpc">C12N5/0692</class-ref>, <class-ref scheme="cpc">C12N5/0695</class-ref>, with the relevant symbol <class-ref scheme="cpc">A61K2035/124</class-ref> for in vivo Application; there are no symbols for the resulting differentiated cells.</paragraph-text></list-item><list-item><paragraph-text type="body">Modified Cells, Fused Cells: <class-ref scheme="cpc">C12N5/10</class-ref> is closed and should not be used; relevant information not related to the genetic enginee&#8203;ring itself can be classified in <class-ref scheme="cpc">C12N5/06</class-ref> with an <class-ref scheme="cpc">C12N2510/00</class-ref> symbol.</paragraph-text></list-item></list><paragraph-text type="body">The technology classified in <class-ref scheme="cpc">C12N5/12</class-ref> and subgroups (fused cells, e.g. hybridomas <class-ref scheme="cpc">C12N5/163</class-ref>, hybridomas for producing a specific antibody <class-ref scheme="cpc">C07K16/00</class-ref>) appears to be mostly obsolete and tech&#8203;nically deprecated.</paragraph-text><paragraph-text type="body">The last overhaul in <class-ref scheme="cpc">C12N5/00</class-ref> (from 2002 onwards) was driven by the surge of stem cell-related applications. In order to both keep track of differentiation processes and maintain stem cell groups to a manageable size, <class-ref scheme="cpc">C12N2506/00</class-ref> was introduced. It also appeared that, with paperless classification and online search, it would be better to move cell-type specific media and supports to the corres&#8203;ponding cell group; <class-ref scheme="cpc">C12N2500/00</class-ref> - <class-ref scheme="cpc">C12N2502/00</class-ref> and, later <class-ref scheme="cpc">C12N2531/00</class-ref> - <class-ref scheme="cpc">C12N2533/00</class-ref>, were introduced and <class-ref scheme="cpc">C12N5/00</class-ref> documents deeply indexed during reor&#8203;ga&#8203;ni&#8203;sation (<class-ref scheme="cpc">C12N2531/00</class-ref> - <class-ref scheme="cpc">C12N2533/00</class-ref> indexing is less thorough because it was actually performed after reorganisation of <class-ref scheme="cpc">C12N5/06</class-ref> was complete). To avoid duplicating in whole the existing hierarchies for proteins (<class-ref scheme="cpc">A61K38/00</class-ref>, <class-ref scheme="cpc">C07K14/00</class-ref>), enzymes (<class-ref scheme="cpc">C12N9/00</class-ref>), antibodies (<class-ref scheme="cpc">C07K16/00</class-ref>) and chemicals (<class-ref scheme="cpc">A61K31/00</class-ref>, <class-ref scheme="cpc">C07</class-ref>, <class-ref scheme="cpc">C08</class-ref>, etc), <class-ref scheme="cpc">C12N2501/00</class-ref> was organised by signalling pathway, so that a ligand, its receptor, anti&#8203;bodies thereof and any &quot;small organic molecule&quot; with agonist or antagonist activity could share one single symbol.</paragraph-text><paragraph-text type="body">Further cell groups were introduced, with mnemonic letters wherever possible. It has been submitted that the older layers of classification are organised by cell type while the newer layers are often in terms of organs; this is correct, but, taking into account that each different organ is asso&#8203;ciated with only a limited number of specific cell types, there should be no ambiguity in practice.</paragraph-text><paragraph-text type="body">Blood and bone marrow-related groups were completely remodelled for more specificity, giving an opportunity to get rid of the lymphoid/myeloid distinction which proved to be proble&#8203;ma&#8203;tic (notably dendritic cells are heterogenous and may derive from both lineages). In order to restrict as much as possible the large group for haematopoietic stem cells, committed progenitors were reclas&#8203;sified with their progeny but this policy was not consistently considered elsewhere.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0607</class-ref> (pluripotent adult stem cells) derives from a practical issue, which ultimately stems from our poor understanding of stem cells in general. While stem cells are all the rage, it must be kept in mind that actually very few cells have been proved to be stem: Haema&#8203;to&#8203;poietic stem cells have only been &quot;purified&quot; to a few percent of a population, and that&apos;s with mouse cells, not even in humans. Mesenchymal stem cells are currently sourced from various tissues (bone marrow, circulating blood, adipose tissue) which are assumed to yield similar or iden&#8203;tical cells; it has also not been demonstrated whether such MSC populations actually contain true multi&#8203;potent cells rather than a mixture of various uni- or bi&#8203;potent progenitors. Evidence of true stem&#8203;ness, at clonal level, is only available for embryonic stem cells; unfortunately, it is also known that ES are a laboratory artefact&#8212;a wonderful artefact, but an artefact nevertheless. <class-ref scheme="cpc">C12N5/0607</class-ref> was intended as a temporary fix, carefully monitored, to be eventually dispersed into existing groups or better redefined, taking advantage of further insights into &quot;stemness&quot;.</paragraph-text><paragraph-text type="body">And then induced pluripotent stem cells (iPS) appeared, and a specific group was quickly needed to cover this technology.</paragraph-text><paragraph-text type="body">Classification strategy according to subject-matter</paragraph-text><paragraph-text type="body">For the sake of completeness, classification should be considered in all technical fields where they may be of interest. Common targets for additional classification include:</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="cpc">A61K35/00</class-ref> (chemically &quot;undefined&quot; pharmaceutical compositions, including cells)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">A61K39/00</class-ref> (vaccines/immunology)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">A61K31/00</class-ref>, <class-ref scheme="cpc">A61K38/00</class-ref>, <class-ref scheme="cpc">A61K47/00</class-ref> (pharmacy)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref> (gene therapy)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">A61L27/00</class-ref> (implants, esp. <class-ref scheme="cpc">A61L27/38</class-ref>), and/or <class-ref scheme="cpc">A61F2/00</class-ref> (prostheses)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">A61M</class-ref> (medical devices)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C07K16/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref> (proteins)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12M</class-ref> (apparatuses for cell culture)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N1/00</class-ref> (bacteria, fungi)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">A01H</class-ref> (plants, for documents classified with the symbol <class-ref scheme="cpc">C12N5/04</class-ref> or <class-ref scheme="cpc">C12N5/14</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N7/00</class-ref> (viruses, including cells for virus culture)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N15/11</class-ref>(RNAi etc.)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N15/85</class-ref> (vectors, transgenic animals)</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">G01N33/50</class-ref> (testing), <class-ref scheme="cpc">C12Q1/02</class-ref>, <class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></list-item><list-item><paragraph-text type="body">but also <class-ref scheme="cpc">G01N1/00</class-ref> - <class-ref scheme="cpc">G01N1/30</class-ref> and <class-ref scheme="cpc">B01</class-ref> - <class-ref scheme="cpc">B05</class-ref> classes referenced therein (analysis and apparatuses)</paragraph-text></list-item></list><paragraph-text type="body">Cells per se, tissues per se: <class-ref scheme="cpc">C12N5/0602</class-ref>, with the exception of vaccines.</paragraph-text><paragraph-text type="body">Cells for vaccines are allocated a symbol in <class-ref scheme="cpc">A61K39/00</class-ref> and subgroups according to the antigen, a symbol in <class-ref scheme="cpc">A61K2039/51</class-ref> and subgroups and a symbol in <class-ref scheme="cpc">C12N5/00</class-ref> and subgroups, when the invention is directed to the culture process.</paragraph-text><paragraph-text type="body">For cellular immunotherapy, a symbol can be allocated in <class-ref scheme="cpc">C12N5/0634</class-ref> or <class-ref scheme="cpc">C12N5/0636</class-ref> - <class-ref scheme="cpc">C12N5/064</class-ref> with an appropriate symbol in <class-ref scheme="cpc">A61K40/00</class-ref> and subgroups and <class-ref scheme="cpc">A61K2239/00</class-ref> - <class-ref scheme="cpc">A61K2239/59</class-ref> if the invention is the invention is directed to the culture process.</paragraph-text><paragraph-text type="body">Medical preparations containing living animal cells (other than vaccines):</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0601</class-ref>, <class-ref scheme="cpc">C12N5/0602</class-ref>, etc with the relevant symbol <class-ref scheme="cpc">A61K35/12</class-ref> or <class-ref scheme="cpc">A61K48/00</class-ref>.</paragraph-text><paragraph-text type="body">Considered for classification in <class-ref scheme="cpc">A61K35/00</class-ref>.</paragraph-text><paragraph-text type="body">Transformed cells, Immortalised cells: Quite often, transfected cells are nothing more than a means to produce a protein (<class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C07K16/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref>, possibly gene therapy, <class-ref scheme="cpc">A61K48/00</class-ref>) or to perform biochemical tests or screening assays (<class-ref scheme="cpc">G01N33/50</class-ref> or <class-ref scheme="cpc">C12Q1/02</class-ref>): these cases do not deserve clas&#8203;si&#8203;fi&#8203;ca&#8203;tion in <class-ref scheme="cpc">C12N5/00</class-ref> and no further <class-ref scheme="cpc">C12N2510/00</class-ref> symbol is required. If, and only if, the document is clas&#8203;sified in <class-ref scheme="cpc">C12N5/00</class-ref> for another reason or the transformation itself is important (e.g. a cell immor&#8203;talised by telomerase, <class-ref scheme="cpc">C12N2510/04</class-ref>), an <class-ref scheme="cpc">C12N2510/00</class-ref> symbol is used in combination with the <class-ref scheme="cpc">C12N5/06</class-ref> class of the cell type. If the cell type is not relevant, the document pertains to a general method of transfection and should be classified in <class-ref scheme="cpc">C12N15/00</class-ref>.</paragraph-text><paragraph-text type="body">Also, claims to a transformed cell isolated from a transgenic animal (possibly made for that sole purpose) need not be classified in <class-ref scheme="cpc">C12N5/0602</class-ref> even the cell type is specified: Consider classification in <class-ref scheme="cpc">C12N15/85</class-ref> and add an additional <class-ref scheme="cpc">C12N2517/00</class-ref> symbol. The same apply to fused cells (e.g. hybridomas), which are classified in <class-ref scheme="cpc">C12N5/12</class-ref> and subgroups only if their interest goes beyond the antibody they produce (forward to <class-ref scheme="cpc">C07K16/00</class-ref>).</paragraph-text><paragraph-text type="body">Apparatuses for cell purification are not classified at all in <class-ref scheme="cpc">C12N5/00</class-ref>; if the application concerns a particular (novel) reagent, a particular device or a method specifically tied to a particular device, in many cases it will be classified fully outside of <class-ref scheme="cpc">C12N5/00</class-ref>. The typical document retained in <class-ref scheme="cpc">C12N5/00</class-ref> pertains to the use of a combination of (known) reagents (combinations of markers) for isolating a given cell type.</paragraph-text><paragraph-text type="body">Culture medium:</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0018</class-ref> - <class-ref scheme="cpc">C12N5/0056</class-ref> for a &quot;universal&quot; medium, including medium for &quot;generic cells&quot;.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N5/06</class-ref> and subgroups for a medium dedicated to a specific cell type.</paragraph-text><paragraph-text type="body">In all cases, all specified components are classified with <class-ref scheme="cpc">C12N2500/00</class-ref> - <class-ref scheme="cpc">C12N2502/00</class-ref> symbols. Many documents pertaining to culture media fall under <class-ref scheme="cpc">C12N5/06</class-ref> in CPC, but belong to <class-ref scheme="cpc">C12N5/00</class-ref> and subgroups thereof under IPC.</paragraph-text><paragraph-text type="body">Culture support:</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0068</class-ref> and <class-ref scheme="cpc">C12N5/0075</class-ref> possibly add a <class-ref scheme="cpc">C12N5/06</class-ref> (and subgroups) class for the cell used in the examples if it is relevant. <class-ref scheme="cpc">C12N5/0601</class-ref>, <class-ref scheme="cpc">C12N5/0602</class-ref>&#8230; in the less common case where the support is type-specific classify with <class-ref scheme="cpc">C12N2533/00</class-ref> and <class-ref scheme="cpc">C12N2531/00</class-ref> symbols.</paragraph-text><paragraph-text type="body">Cell culture apparatus:</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12M</class-ref> Outside of the scope of this document.</paragraph-text><paragraph-text type="body">Cell culture process:</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0601</class-ref>, <class-ref scheme="cpc">C12N5/0602</class-ref> etc.</paragraph-text><paragraph-text type="body">Classify active agents with <class-ref scheme="cpc">C12N2501/00</class-ref>, <class-ref scheme="cpc">C12N2500/00</class-ref>, <class-ref scheme="cpc">C12N2502/00</class-ref> symbols as applicable.</paragraph-text><paragraph-text type="body">Differentiation process:</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0601</class-ref>, <class-ref scheme="cpc">C12N5/0602</class-ref> etc. for the resulting cell.</paragraph-text><paragraph-text type="body">Classify differentiation agents with <class-ref scheme="cpc">C12N2501/00</class-ref>, <class-ref scheme="cpc">C12N2500/00</class-ref>, <class-ref scheme="cpc">C12N2502/00</class-ref> symbols as applicable.</paragraph-text><paragraph-text type="body">The differentiation of a lineage-restricted stem cell into the corresponding, expected, progeny (from a <class-ref scheme="cpc">C12N5/0606</class-ref>, <class-ref scheme="cpc">C12N5/0611</class-ref>, <class-ref scheme="cpc">C12N5/0623</class-ref> etc progenitor or stem cell to a <class-ref scheme="cpc">C12N5/0603</class-ref>, <class-ref scheme="cpc">C12N5/0608</class-ref>, <class-ref scheme="cpc">C12N5/0613</class-ref> etc terminal cell within the same branch of the hierarchy) is not further classified; differentiation of pluripotent cells (<class-ref scheme="cpc">C12N5/0606</class-ref>, <class-ref scheme="cpc">C12N5/0607</class-ref>, <class-ref scheme="cpc">C12N5/0611</class-ref>) and &quot;unexpected&quot; differentiation processes, such as transdifferentiation to a different branch of the hierarchy or dedifferentiation (from a differentiated cell into a more primitive or more potent cell), are classified with a <class-ref scheme="cpc">C12N2506/00</class-ref> symbol for the initial cell.</paragraph-text><paragraph-text type="body">Tissue culture, 3D culture, tissue equivalents:</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0062</class-ref> for a generic process.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0601</class-ref>, <class-ref scheme="cpc">C12N5/0602</class-ref> etc. for a specific tissue defined by one single cell type or for ex vivo culture of tissues (e.g. skin explants <class-ref scheme="cpc">C12N5/0677</class-ref>).</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N5/0697</class-ref> etc. for an artificial tissue construct requiring the association of more than one type of cells to achieve its function; classify all cell types with <class-ref scheme="cpc">C12N2502/00</class-ref> symbols.</paragraph-text><paragraph-text type="body">Tests, screening assays on cells or tissue equivalents:</paragraph-text><paragraph-text type="body">Classify in <class-ref scheme="cpc">G01N33/50</class-ref> or <class-ref scheme="cpc">C12Q1/02</class-ref>.</paragraph-text><paragraph-text type="body">Classification with <class-ref scheme="cpc">C12N2503/00</class-ref> symbols is only intended to avoid superfluous double classification when the cell in itself is of interest for <class-ref scheme="cpc">C12N5/00</class-ref> and the testing process is not inventive.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N5/0025</classification-symbol><definition-title>{Culture media for plant cell or plant tissue culture}</definition-title><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">See also <class-ref scheme="cpc">A01H4/00</class-ref> through <class-ref scheme="cpc">A01H4/008</class-ref></paragraph-text></section-body></relationship></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N5/04</classification-symbol><definition-title>Plant cells or tissues {(culture media <class-ref scheme="cpc">C12N5/0025</class-ref>)}</definition-title><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">See also <class-ref scheme="cpc">A01H4/00</class-ref> through <class-ref scheme="cpc">A01H4/008</class-ref>, <class-ref scheme="cpc">C12N1/12</class-ref>, <class-ref scheme="cpc">C12N5/14</class-ref> and <class-ref scheme="cpc">A01G33/00</class-ref></paragraph-text></section-body></relationship></definition-item>
<definition-item date-revised="2015-03-01"><classification-symbol scheme="cpc">C12N5/0606</classification-symbol><definition-title>{Pluripotent embryonic cells, e.g. embryonic stem cells [ES]  (embryonic germ cells <class-ref scheme="cpc">C12N5/0611</class-ref>, induced pluripotent stem cells <class-ref scheme="cpc">C12N5/0696</class-ref>)}</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">A &quot;pluripotent&quot; cell is a somatic stem cell which can differentiate into cells of at least two of the three somatic lineages (ectoderm, mesoderm and endoderm). Totipotent cells are classified with pluripotent cells. A &quot;totipotent&quot; cell can differentiate into all somatic lineages (ectoderm, mesoderm and endoderm), the germ line and extra-embryonic tissues such as the placenta</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2015-03-01"><classification-symbol scheme="cpc">C12N5/0607</classification-symbol><definition-title>{Non-embryonic pluripotent stem cells, e.g. MASC  (induced pluripotent stem cells <class-ref scheme="cpc">C12N5/0696</class-ref>)}</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">A &quot;pluripotent&quot; cell is a somatic stem cell which can differentiate into cells of at least two of the three somatic lineages (ectoderm, mesoderm and endoderm). Totipotent cells are classified with pluripotent cells. A &quot;totipotent&quot; cell can differentiate into all somatic lineages (ectoderm, mesoderm and endoderm), the germ line and extra-embryonic tissues such as the placenta</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2015-03-01"><classification-symbol scheme="cpc">C12N5/0647</classification-symbol><definition-title>{Haematopoietic stem cells; Uncommitted or multipotent progenitors}</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">A &quot;multipotent&quot; cell is restricted to one lineage.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N5/14</classification-symbol><definition-title>Plant cells</definition-title><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">See also <class-ref scheme="cpc">C12N15/02</class-ref></paragraph-text></section-body></relationship></definition-item>
<definition-item date-revised="2025-01-01"><classification-symbol scheme="cpc">C12N5/52</classification-symbol><definition-title>{Chemical aspects of preservation of animal cells or human cells  (Preservation of excised living parts of human of bodies <class-ref scheme="cpc">A01N1/10</class-ref>)}</definition-title><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Containers specially adapted for collecting and storing blood and plasma are classified in <class-ref scheme="cpc">A61J1/05</class-ref>.</paragraph-text></section-body></relationship><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Preservation of excised living parts of human bodies</paragraph-text></table-column><table-column><paragraph-text type="body"> <class-ref scheme="cpc">A01N1/10</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item date-revised="2025-01-01"><classification-symbol scheme="cpc">C12N5/54</classification-symbol><definition-title>{Mechanical aspects of preservation of animal cells or human cells; Apparatus or containers therefor  (Preservation of excised living parts of human of bodies <class-ref scheme="cpc">A01N1/10</class-ref>)}</definition-title><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Preservation of excised living parts of human bodies</paragraph-text></table-column><table-column><paragraph-text type="body"> <class-ref scheme="cpc">A01N1/10</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Containers specially adapted for collecting, storing or administering blood or plasma</paragraph-text></table-column><table-column><paragraph-text type="body"> <class-ref scheme="cpc">A61J1/05</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2025-01-01"><classification-symbol scheme="cpc">C12N5/546</classification-symbol><definition-title>{Non-refrigerated containers specially adapted for transporting or storing animal cells or human cells whilst preserving}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Containers not comprising mechanical means that actively alter temperature. The use of phase change materials, e.g. ice, to passively keep the cells or tissues cool is not considered &quot;active&quot; refrigeration.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item date-revised="2025-01-01"><classification-symbol scheme="cpc">C12N5/548</classification-symbol><definition-title>{with provisions specially adapted for transporting}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Documents specifically addressing a transport aspect, e.g. providing means to counteract shocks or tilting.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Containers that are suitable for transport but do not comprise provisions specifically for transporting should be classified in&#160;<class-ref scheme="cpc">C12N5/542</class-ref>, <class-ref scheme="cpc">C12N5/546</class-ref>&#160;or&#160;<class-ref scheme="cpc">C12N5/547</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2025-01-01"><classification-symbol scheme="cpc">C12N5/562</classification-symbol><definition-title>{Temperature processes, e.g. following predefined temperature changes over time}</definition-title><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Processes comprising temperature changes inherently involved in freezing or cryopreservation wherein no specific technical effect is disclosed for the temperature profile are not classified in this group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-02-01"><classification-symbol scheme="cpc">C12N7/00</classification-symbol><definition-title>Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof  (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, <class-ref scheme="cpc">A61K39/00</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Viruses are ultramicroscopic (20 to 300 nm in diameter), metabolically inert, infectious agents that replicate only within the cells of living hosts, mainly bacteria, plants, and animals: composed of an RNA or DNA core, a protein coat, and, in more complex types, a surrounding envelope.</paragraph-text><paragraph-text type="body">Note that a virus (or VLP) as such is not considered a nanoparticle even if it falls under the size constraints of nanotechnology (see <class-ref scheme="cpc">B82Y5/00</class-ref>).</paragraph-text><list><list-item><paragraph-text type="body">Viruses as such, e.g. new isolates, mutants or their genomic sequences</paragraph-text></list-item><list-item><paragraph-text type="body">New viral genes, new structural/functional aspects of known viral genes</paragraph-text></list-item><list-item><paragraph-text type="body">Virus like particles (VLP)</paragraph-text></list-item><list-item><paragraph-text type="body">Uses of virus other than therapeutic or vaccine, e.g. disinfectant</paragraph-text></list-item><list-item><paragraph-text type="body">Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent</paragraph-text></list-item><list-item><paragraph-text type="body">Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory</paragraph-text></list-item><list-item><paragraph-text type="body">Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein</paragraph-text></list-item><list-item><paragraph-text type="body">Use of virus or viral particle as a vehicle, e.g. encapsulating small organic molecule</paragraph-text></list-item><list-item><paragraph-text type="body">Use of virus or viral particle as a vector, e.g. encapsulating viral genome or elements thereof as genetic vector</paragraph-text></list-item><list-item><paragraph-text type="body">Chimeric viral vector comprising heterologous viral elements for production of another viral vector</paragraph-text></list-item><list-item><paragraph-text type="body">Special targeting system for viral vectors</paragraph-text></list-item><list-item><paragraph-text type="body">Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles</paragraph-text></list-item><list-item><paragraph-text type="body">Methods of inactivation or attenuation by genetic engineering, by chemical treatment, by serial passage</paragraph-text></list-item><list-item><paragraph-text type="body">Demonstrated in vivo effect</paragraph-text></list-item></list></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Phage display</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1037</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Therapeutic viral non-coding nucleic acid (siRNA)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/11</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antiviral drugs</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K31/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies against viral antigens</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K16/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Diagnostics using viral genes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/70</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Diagnostics using viral protein </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/569</class-ref>, <class-ref scheme="cpc">G01N33/576</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Transgenic animal model for infectious disease</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/8509</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Further aspects of vectors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2800/00</class-ref> - <class-ref scheme="cpc">C12N2999/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Animal model for infectious disease</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01K2267/0337</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Virus capsids or envelopes enclosing drugs</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K9/5184</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Therapeutic use of virus not as vaccine</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K35/76</class-ref>, <class-ref scheme="cpc">A61K35/13</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Therapeutic use of viral proteins, not as vaccine</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K38/16</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Further aspects of (viral) vaccines</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="not-mapped">A61K2039/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Viral vaccine</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/12</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Polyvalent vaccine</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/295</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Vaccine characterised by adjuvant</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K39/39</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Gene Therapy</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fusion proteins</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K2319/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Measuring or testing involving virus or bacteriophage</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/70</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The complexity of the field is compounded by the large number of available viruses and the increase in their corresponding (therapeutic) uses. In this scheme, taxonomic indexing codes are assigned (<class-ref scheme="cpc">C12N2710/00</class-ref>-<class-ref scheme="cpc">C12N2796/00</class-ref> series to define which virus is used in a given invention. These codes are extended by two digits to define the specific use(s) of the virus or viral component.</paragraph-text><paragraph-text type="body">Allocation of these codes is compulsory for all relevant virus subject-matter, according to the rules defined below.</paragraph-text><paragraph-text type="body">The use of the subdivisions in <class-ref scheme="cpc">C07K14/005</class-ref>-<class-ref scheme="cpc">C07K14/19</class-ref>, <class-ref scheme="cpc">C12N7/00</class-ref>-<class-ref scheme="cpc">C12N7/08</class-ref> and <class-ref scheme="cpc">C12N15/86</class-ref>-<class-ref scheme="cpc">C12N15/869</class-ref> is discontinued since the taxonomy within said classification ranges is incomplete and inconsistent. Only <class-ref scheme="cpc">A61K39/12</class-ref>, <class-ref scheme="cpc">C07K14/005</class-ref>, <class-ref scheme="cpc">C12N7/00</class-ref> and <class-ref scheme="cpc">C12N15/86</class-ref> will be given in relevant cases, as indicated below.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N7/00</class-ref> should be given when no other viral (<class-ref scheme="cpc">A61K39/12</class-ref>, <class-ref scheme="cpc">C07K14/005</class-ref>, <class-ref scheme="cpc">C12N15/86</class-ref>) or other group is appropriate, since giving at least one group as invention information is mandatory.</paragraph-text><paragraph-text type="body">The specific codes in the <class-ref scheme="cpc">C12N2710/00</class-ref> - <class-ref scheme="cpc">C12N2796/00</class-ref> ranges have the format <class-ref scheme="not-mapped">C12N27xx/xxxyy</class-ref>. The first part of the code indicates the structural element of the invention, namely the specific virus to which the invention relates. The two last digits before the &apos;/&apos; and the first three digits after the &apos;/&apos; represent the taxonomic location of the virus and the last place rule applies:</paragraph-text><list><list-item><paragraph-text type="body"><class-ref scheme="not-mapped">C12N2710/xxx</class-ref>: double stranded DNA virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="not-mapped">C12N2720/xxx</class-ref>: double stranded RNA virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="not-mapped">C12N2730/xxx</class-ref>: reverse transcribing DNA virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="not-mapped">C12N2740/xxx</class-ref>: reverse transcribing RNA virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="not-mapped">C12N2750/xxx</class-ref>: single stranded DNA virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="not-mapped">C12N2760/xxx</class-ref>: single stranded RNA virus negative-sense</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="not-mapped">C12N2770/xxx</class-ref>: single stranded RNA virus positive-sense</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="not-mapped">C12N2780/xxx</class-ref>: viroids and subviral agents</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="not-mapped">C12N2790/xxx</class-ref>: naked RNA Virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="not-mapped">C12N2792/xxx</class-ref>: archaeabacteria virus</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="not-mapped">C12N2795/xxx</class-ref>: bacteriophage</paragraph-text></list-item></list><paragraph-text type="body">Specific further aspects of viruses that are sufficiently disclosed in the application and worth classifying are assigned in combination with the taxonomy by addition of codes of two digits (yy) at the end of the taxonomic information (xx/xxx). The scope of the information covered by the last two digits is as defined below.</paragraph-text><paragraph-text type="body">If multiple functions are disclosed for the same virus or viral component, multiple codes of the format <class-ref scheme="not-mapped">C12N27xx/xxxyy</class-ref> are given:</paragraph-text><list><list-item><paragraph-text type="body">11: General: This code covers aspects of viruses that do not fall under the codes defined below. Codes 21-64 take precedence.</paragraph-text></list-item><list-item><paragraph-text type="body">21: Viruses as such: This code corresponds to IPC <class-ref scheme="cpc">C12N7/00</class-ref> and covers completely new virus species, as well as new isolates of known viruses. Said viruses may be for instance defined by their genomic sequences or deposit numbers. Disclosed uses of said viruses as indicated below are additionally classified. If the virus per se is an essential feature of the invention, <class-ref scheme="cpc">C12N7/00</class-ref> is to be given.</paragraph-text></list-item><list-item><paragraph-text type="body">22: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes: This code corresponds to IPC <class-ref scheme="cpc">C07K14/005</class-ref>-<class-ref scheme="not-mapped">19</class-ref> and encompasses newly identified open reading frames and their expression products, as well as newly identified forms of known viral proteins and genes. Furthermore new mutants, fragments, epitopes and fusion proteins of viral proteins are included. When such gene or protein relates to self-assembling capsids, code 23 for VLP is given. Codes in the <class-ref scheme="cpc">C07K2319/00</class-ref> range are to be added for disclosed fusion proteins. Additional aspects of said proteins and genes as listed below should be considered, as well as aspects covered by other parts of the classification scheme e.g. in diagnostics (<class-ref scheme="cpc">G01N33/00</class-ref>, <class-ref scheme="cpc">C12Q1/00</class-ref>) for antibody production (<class-ref scheme="cpc">C07K16/00</class-ref>), in therapy (<class-ref scheme="cpc">A61K38/162</class-ref>), with enzyme function (<class-ref scheme="cpc">C12N9/00</class-ref>), using RNAi for viral protein (<class-ref scheme="cpc">C12N15/11</class-ref>), codon optimised (<class-ref scheme="cpc">C12N2800/22</class-ref>). If the protein or its gene is an essential feature of the invention, also <class-ref scheme="cpc">C07K14/005</class-ref> is to be given, together with the code ending with 22.</paragraph-text></list-item><list-item><paragraph-text type="body">23: Virus like particles, VLP: VLPs to be classified here are self-assembling viral protein complexes lacking the corresponding viral genome. This code is only to be given when the VLP is an essential feature of the invention.</paragraph-text></list-item><list-item><paragraph-text type="body">31: Uses of virus other than therapeutic or vaccine, e.g., use of bacteriophages as disinfectant: N.B. , &apos;Processes using viruses or cell lines&apos; is not used.</paragraph-text></list-item><list-item><paragraph-text type="body">32: Use of virus as therapeutic agent, other than vaccine, e.g. cytolytic viruses for tumor therapy: The class <class-ref scheme="cpc">A61K35/76</class-ref> should be considered in accordance with the classification rules in said field, when the therapeutic activity is an essential feature of the invention.</paragraph-text></list-item><list-item><paragraph-text type="body">33: Use of viral protein for therapeutic application other than vaccine: This code corresponds to IPC <class-ref scheme="cpc">A61K38/16</class-ref>, and is given for viral proteins that have therapeutic activity, for instance cytotoxic, apoptosis inducing or anti-inflammatory viral proteins. If the therapeutic use of the viral protein is an essential feature of the invention, also <class-ref scheme="cpc">A61K38/16</class-ref> should be considered in accordance with the classification rules in said field.</paragraph-text></list-item><list-item><paragraph-text type="body">34: Use of virus or viral component as vaccine: This code corresponds to IPC <class-ref scheme="cpc">A61K39/12</class-ref>-<class-ref scheme="not-mapped">29</class-ref> and covers the various types of viral vaccines, e.g. live attenuated or inactivated virus, VLP, viral protein or nucleic acid. Further classification of the vaccine aspects needs to be done in accordance with the specific classification rules in said field. In particular, if multiple viral antigens are combined of which at least one is viral, <class-ref scheme="cpc">A61K39/295</class-ref> needs to be given; if the vaccine is characterised by the adjuvant, <class-ref scheme="cpc">A61K39/39</class-ref> should be added. The relevant codes from <class-ref scheme="not-mapped">A61K2039/00</class-ref> for further vaccine aspects should also be given. If the use as a vaccine is an essential feature of the invention(s), also <class-ref scheme="cpc">A61K39/12</class-ref> is to be given, together with the code ending with 34.</paragraph-text></list-item><list-item><paragraph-text type="body">41: Use of virus or viral particle as a vector, specific codes 42-45 take precedence.</paragraph-text></list-item><list-item><paragraph-text type="body">42: Use of viral particle as vehicle: This code is given when no genetic material derived from the viral genome is transported by the viral vector, but rather encapsulated agents, e.g. small nucleic acids or organic compounds. Codes in the <class-ref scheme="cpc">C12N2810/00</class-ref> series needs to be considered when the surface of the vector is altered to influence targeting.</paragraph-text></list-item><list-item><paragraph-text type="body">43: Use of viral genome or elements thereof as genetic vector: This code corresponds to IPC <class-ref scheme="cpc">C12N15/86</class-ref>-<class-ref scheme="cpc">C12N15/869</class-ref> and is given when the invention resides in the vector, for instance when no such virus was previously known as genetic vector, when a known viral genetic vector is improved, or when a new property (e.g. tissue tropism) is uncovered and results in (a) new application(s) of a known viral vector. Additional codes from the <class-ref scheme="cpc">C12N2800/00</class-ref>-<class-ref scheme="cpc">C12N2840/00</class-ref> ranges need to be considered. If the vector is an essential feature of the invention, also <class-ref scheme="cpc">C12N15/86</class-ref> is to be given together with codes ending with 43-45.</paragraph-text></list-item><list-item><paragraph-text type="body">44: Chimeric viral vector comprising heterologous viral elements for production of another viral vector: This code is reserved for the viral backbone of said vector, i.e. if a vaccinia viral vector is used to express a lentiviral vector system, the vaccinia aspect is indicated with 44 and the lentiviral vector with 43.</paragraph-text></list-item><list-item><paragraph-text type="body">45: Special targeting system for viral vectors: Influencing cell type specificity by modification of the surface of the virus, the specific targeting element can be further defined by codes in the <class-ref scheme="cpc">C12N2810/00</class-ref> series. If altered tropism is only effected by transcriptional or translational elements, give the relevant codes of the <class-ref scheme="cpc">C12N2830/00</class-ref> or <class-ref scheme="cpc">C12N2840/00</class-ref> series.</paragraph-text></list-item><list-item><paragraph-text type="body">51: Methods of production or purification of viral material: This code corresponds to IPC <class-ref scheme="cpc">C12N7/02</class-ref> and relates to new protocols for producing viral material, e.g. using particular cell types, growing conditions to increase production, or novel purification methods, e.g. defined by specific centrifugation or chromatography steps. Also methods of stabilising virus compositions using cryopreservants or other excipients are classified here. If production, purification or stabilisation are an essential feature of the invention, also <class-ref scheme="cpc">C12N7/00</class-ref> is to be given, together with the code ending with 51.</paragraph-text></list-item><list-item><paragraph-text type="body">52: relating to complementing cells and packaging systems for producing virus or viral particles: This code relates to packaging cells that stably or transiently express viral genes to allow production of virus lacking said genetic information on their genome. This code is also to be given if other aspects of packaging are an important aspect of the invention. If the cells or packaging systems are an essential feature of the invention, also <class-ref scheme="cpc">C12N7/00</class-ref> is to be given, together with the code ending with 52.</paragraph-text></list-item><list-item><paragraph-text type="body">61: Methods of inactivation or attenuation: Codes 62-64 take precedence, this code is only used for methods of inactivation or attenuation not covered below, such as (UV) irradiation. If inactivation or attenuation is an essential feature of the invention, also <class-ref scheme="cpc">C12N7/00</class-ref> is to be given together with codes ending with 61-64.</paragraph-text></list-item><list-item><paragraph-text type="body">62: Methods of inactivation or attenuation by genetic engineering: This code is given when the nature of the attenuating mutation is known and can be reproduced. Virus-like particles are not classified here but with code 23.</paragraph-text></list-item><list-item><paragraph-text type="body">63: Methods of inactivation or attenuation by chemical treatment.</paragraph-text></list-item><list-item><paragraph-text type="body">64: Methods of inactivation or attenuation by serial passage: Selection of new viral strains by (further) serial passage on cell lines, for instance taking modified vaccinia virus Ankara 575 and submitting it to further rounds of serial passage on cells. If mutations have been identified with proven relationship to attenuation, also 62 should be given.</paragraph-text></list-item><list-item><paragraph-text type="body">71: Demonstrated in vivo effect: This code is given when credible in vivo data are presented that are indicative for a (therapeutic) effect in human or animals. For instance data from clinical trials or from highly relevant animal models, such as primates for HIV, or showing protection of cattle from viral disease, e.g. preventing vertical transmission.</paragraph-text></list-item></list></section-body></special-rules></definition-item>
<definition-item date-revised="2017-08-01"><classification-symbol scheme="cpc">C12N9/00</classification-symbol><definition-title>Enzymes; Proenzymes; Compositions thereof  (preparations containing enzymes for cleaning teeth <class-ref scheme="cpc">A61K8/66</class-ref>, <class-ref scheme="cpc">A61Q11/00</class-ref>; medicinal preparations containing enzymes or proenzymes <class-ref scheme="cpc">A61K38/43</class-ref>; enzyme containing detergent compositions <class-ref scheme="cpc">C11D</class-ref>; {enzymes with nucleic acid structure, e.g. ribozymes, <class-ref scheme="cpc">C12N15/113</class-ref>}); Processes for preparing, activating, inhibiting, separating or purifying enzymes  (preparation of malt <class-ref scheme="cpc">C12C1/00</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Enzymes or proenzymes and compositions containing enzymes or proenzymes.</paragraph-text></list-item><list-item><paragraph-text type="body">Processes for preparing, activating, inactivating, inhibiting, stabilizing, separating, or purifying enzymes.</paragraph-text></list-item><list-item><paragraph-text type="body">Genes and other polynucleotides coding for enzymes.</paragraph-text></list-item><list-item><paragraph-text type="body">Non-coding nucleic acid sequences, e.g. promoters, operators, derived from genes or operons coding for enzymes.</paragraph-text></list-item><list-item><paragraph-text type="body">Fragments of enzymes and nucleic acids encoding enzymes (fragments of less than 5 amino acids are also classified in <class-ref scheme="cpc">C07K</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body">Fusion proteins comprising an enzyme or part thereof.</paragraph-text></list-item><list-item><paragraph-text type="body">Antibodies with enzymatic/catalytic activity, e.g. abzymes.</paragraph-text></list-item><list-item><paragraph-text type="body">Crystallized enzymes.</paragraph-text></list-item></list></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><list><list-item><paragraph-text type="body">Biocidal, pest repellent, pest attractant or plant growth regulatory activity of compounds or preparations containing enzymes is further classified in subclass <class-ref scheme="cpc">A01H</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Therapeutic activity of compounds containing enzymes, is further classified in subclass <class-ref scheme="cpc">A61K</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Uses of cosmetics or similar toilet preparations containing microorganisms or enzymes are further classified in subclass <class-ref scheme="cpc">A61Q</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Fragments of less than 5 amino acids are also classified in maingroup <class-ref scheme="cpc">C07K5/00</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Carrier-bound or immobilised enzymes and preparations thereof are further classified in maingroup <class-ref scheme="cpc">C12N11/00</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Treatment of enzymes with electrical or wave energy is further classified in maingroup <class-ref scheme="cpc">C12N13/00</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Operons comprising the genes for several enzymes are also classified in <class-ref scheme="cpc">C12N15/52</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Fusion polypeptides comprising (part of) an enzyme are further classified in <class-ref scheme="cpc">C07K2319/00</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Crystals of enzymes are also classified in <class-ref scheme="cpc">C07K2299/00</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Enzymes are also classified in <class-ref scheme="cpc">C12Y</class-ref> according to their EC number (see special rules section: &quot;Rules for <class-ref scheme="cpc">C12Y</class-ref> in addition to <class-ref scheme="cpc">C12N9/00</class-ref>)</paragraph-text></list-item></list></section-body></relationship><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Catalytic nucleic acids e,g, ribozymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/113</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antisense nucleotides against enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1137</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies against enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K16/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Measuring or testing processes involving enzymes; Compositions therefore (including kits, test papers etc); Preparing such compositions</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassays for enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/573</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><application-references><section-title>Application-oriented references</section-title><section-body><paragraph-text type="preamble">Examples of places where the subject matter of this place is covered when specially adapted, used for a particular purpose, or incorporated in a larger system:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Compositions containing enzymes and use of the compositions and compounds for preservation of bodies of humans or animals or parts thereof</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01N1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Compositions containing enzymes and use of the compositions and compounds for preservation of plants or parts thereof</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01N3/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Biocides, pest repellents or attractants or plant growth regulators containing enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01N63/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bakery products which may contain enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A21D10/00</class-ref>, <class-ref scheme="cpc">A21D13/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Foods or foodstuffs containing enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A23</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Body treating or pharmaceutical preparations containing enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing nucleic acids encoding enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K31/7088</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Medicinal preparations containing genetic material encoding enzymes which is inserted into cells of the living body to treat genetic diseases; Gene therapy</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Bandages, dressings or absorbent pads for physiological fluids containing enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61L15/38</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Antibodies against enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K16/40</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzyme containing detergent compositions</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C11D</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation of malt</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12C1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation of compounds using enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Measuring or testing processes involving enzymes; Compositions therefore (including complete kits, test papers etc); Preparing such compositions</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Immunoassays for enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/573</class-ref></paragraph-text></table-column></table-row></table></section-body></application-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Preparing polynucleotides using enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Food compositions</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A21</class-ref>, <class-ref scheme="cpc">A23</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61L</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptides having more than 20 amino acids being receptors (as they often possess also an enzymatic function)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/705</class-ref> - <class-ref scheme="cpc">C07K14/723</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation of compounds by using enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Instead of the &quot;last place rule&quot; the following rules are applicable for <class-ref scheme="cpc">C12N9/00</class-ref> and subgroups:</paragraph-text><list><list-item><paragraph-text type="body">Enzymes are generally categorised according to the &quot;Nomenclature and Classification of Enzymes&quot; (as valid on 1 April 2011) of the International Commission on Enzymes. Where appropriate, this designation appears in the subgroups in parenthesis. If the information in disclosures is not enough to be able to classify the document in a subgroup for one specific enzyme, classification is done in a higher, less specific, group. This implies that in case of a search for a specific enzyme also such higher groups should be consulted.</paragraph-text></list-item><list-item><paragraph-text type="body">Besides the enzyme itself also fragments (like epitopes) or derivatives (like mutants) thereof, its proenzyme or just its signal sequence, their encoding polynucleotides or non-coding parts (like promoters, operators) of its gene, including methods for their preparation are all classified in the same subgroup. (antisense DNA or RNA against enzymes <class-ref scheme="cpc">C12N15/1137</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body">Documents are only classified in main group <class-ref scheme="cpc">C12N9/00</class-ref> and lower if there is more disclosed of an enzyme than just a name, a supplier, a reference to a further document for its production and the like. Properties like a sequence or mutation, or a method for its production etc. must be disclosed.</paragraph-text></list-item><list-item><paragraph-text type="body">Documents disclosing only lists of sequences with (putative) enzymatic activity are only classified in the last common enzyme group without classes for each mentioned enzyme, unless more information is given than just the sequence with a putative function. For example a long list of sequences comprising only (putative) proteases will be classified in <class-ref scheme="cpc">C12N9/48</class-ref>. If there are also lipases disclosed the general class for hydrolases (<class-ref scheme="cpc">C12N9/14</class-ref>) will be given. A combination with an acyltransferase results in <class-ref scheme="cpc">C12N9/00</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Documents relating to/being valid for only one specific enzyme, like a mutant of a known enzyme, a new enzyme or a purification method specifically adapted to a particular enzyme, are only classified in the most specific and subgroup relating to this specific enzyme. However, it can also be clear from the provided information that, although the examples concern only one enzyme, the invention is also valid for other enzymes (like a specific purification method only exemplified for a pentosyltransferase but applicable for all other glycosyltransferases). Such documents are both classified in the most specific and subgroup for the enzyme in the examples and in a higher common group (in this case <class-ref scheme="cpc">C12N9/1048</class-ref>).</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref> (and <class-ref scheme="cpc">C07K14/00</class-ref>) vs. <class-ref scheme="cpc">C12N15/00</class-ref>: <class-ref scheme="cpc">C12N9/00</class-ref> (and <class-ref scheme="cpc">C07K14/00</class-ref>) stop where <class-ref scheme="cpc">C12N15/00</class-ref> begins. <class-ref scheme="cpc">C12N9/00</class-ref> (and <class-ref scheme="cpc">C07K14/00</class-ref>) are only used for the product (the inventive non-coding sequence of a gene) while <class-ref scheme="cpc">C12N15/00</class-ref> is used for the use of this product (e.g. a promoter present in a vector for the production of other proteins). Non-coding sequences are only classified in <class-ref scheme="cpc">C12N9/00</class-ref> (or <class-ref scheme="cpc">C07K14/00</class-ref>) if they are (part of) the invention. If the non-coding sequence is just an arbitrary choice from more available sequences it is not classified in <class-ref scheme="cpc">C12N9/00</class-ref> (or <class-ref scheme="cpc">C07K14/00</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body">Reporter genes/enzymes like alkaline phosphatase, beta-lactamase etc. are not classified if they are just present for the detection of something else irrespective whether the above prerequisites of sequence, being prepared and the like are fulfilled. If the document however concerns reporter genes with a specifically mentioned property or preparation, classification in the proper group is necessary (fusion polypeptides containing such reporter enzymes are also classified in <class-ref scheme="cpc">C07K2319/61</class-ref>)</paragraph-text></list-item><list-item><paragraph-text type="body">Proteins with more than one function, like many receptors which often also have an enzymatic function, or the so called oncogenes, which, besides being tumour related, also have their original function, are classified in all groups concerning their different functions/activities. Depending on the discovery of further different functions older documents may still be present in only one class. Such documents are not systematically reclassified. For search purposes both groups should be consulted.</paragraph-text></list-item><list-item><paragraph-text type="body">Enzymes prepared by recombinant DNA technology are not classified according to the host used, but according to the original organism from which the encoding nucleotides were obtained, e.g. HIV protease expressed in E. coli is classified with viral proteases</paragraph-text></list-item><list-item><paragraph-text type="body">Rules for <class-ref scheme="cpc">C12Y</class-ref> in addition to <class-ref scheme="cpc">C12N9/00</class-ref>: Enzymes are classified additionally in <class-ref scheme="cpc">C12Y</class-ref> according to their full EC number (EC a.b.c.d.). An additional <class-ref scheme="cpc">C12Y</class-ref> symbol is also allocated even when a subgroup specific for a single enzyme (EC number) already exists in <class-ref scheme="cpc">C12N9/00</class-ref>. Thus, thrombin (EC 3.4.21.5), for which a single subgroup, <class-ref scheme="cpc">C12N9/6429</class-ref>, exists, will additionally be allocated the appropriate <class-ref scheme="cpc">C12Y</class-ref> symbol. (This double classification is of potential use for other areas of technology (e.g. food chemistry, detergents) where <class-ref scheme="cpc">C12Y</class-ref> classification is used because a more specific classification scheme for enzymes in these areas is not present). A less specific <class-ref scheme="cpc">C12Y</class-ref> symbol (e.g. EC a.b.c.) is only used in addition to a <class-ref scheme="cpc">C12N9/00</class-ref> symbol if the subject-matter to be classified concerns a group of enzymes with a common activity AND there is no equivalent group present in <class-ref scheme="cpc">C12N9/00</class-ref> for enzymes with the common activity. For example, a document describes the purification of carboxy-lyases (EC 4.1.1.). <class-ref scheme="cpc">C12N9/88</class-ref> (lyases, EC 4.) is the closest symbol in <class-ref scheme="cpc">C12N9/00</class-ref>, thus the document is classified in <class-ref scheme="cpc">C12N9/88</class-ref> and <class-ref scheme="cpc">C12Y401/01</class-ref>. However a document describing the purification of hexosyl transferases is classified ONLY in <class-ref scheme="cpc">C12N9/1051</class-ref>.</paragraph-text></list-item></list></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Antisense</paragraph-text></table-column><table-column><paragraph-text type="body">DNA or RNA composed of the complementary sequence to the target DNA/RNA</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzyme</paragraph-text></table-column><table-column><paragraph-text type="body">Proteinaceous materials, which cause a chemical change in a starting material without being consumed in the reaction.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fusion polypeptide</paragraph-text></table-column><table-column><paragraph-text type="body">A polypeptide consisting of (parts of) two or more different proteins covalently linked to each other by a peptide bond</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Kit</paragraph-text></table-column><table-column><paragraph-text type="body">A collection of individual reagents for use in an assay grouped together but being present as separate entities in separate compartments </paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Mutation</paragraph-text></table-column><table-column><paragraph-text type="body">Any change that alters the sequence of bases along the DNA thereby changing the genetic material of a microorganism.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Non-coding nucleic acid sequence</paragraph-text></table-column><table-column><paragraph-text type="body">Nucleic acid sequence which does not contain information for the amino acid sequence of a gene product.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Operon</paragraph-text></table-column><table-column><paragraph-text type="body">A DNA construct containing a cluster of genes under the control of a single regulatory signal or promoter</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Proenzyme</paragraph-text></table-column><table-column><paragraph-text type="body">An enzyme precursor</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Ribozyme</paragraph-text></table-column><table-column><paragraph-text type="body">RNA molecule capable of catalysing a chemical reaction</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Signal sequence</paragraph-text></table-column><table-column><paragraph-text type="body">A 3-60 amino acids long peptide that directs the transport of the protein that is attached to it</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2017-08-01"><classification-symbol scheme="cpc">C12N9/52</classification-symbol><definition-title>derived from bacteria {or Archaea}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Proteinases (, e.g. Endopeptidases (3.4.21 - 3.4.25)) derived from bacteria or proteinases derived from Archaea, formerly known as Archaebacteria.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item date-revised="2015-03-01"><classification-symbol scheme="cpc">C12N9/96</classification-symbol><definition-title>Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">General methods for the stabilisation of enzymes.</paragraph-text></list-item><list-item><paragraph-text type="body">Adducts of enzymes with a specific compound resulting in a more stabile enzymes and their preparation.</paragraph-text></list-item><list-item><paragraph-text type="body">Enzyme compositions with specific physical properties of pH, temperature, concentration etc. resulting in a better stability of the enzymes and their preparation.</paragraph-text></list-item><list-item><paragraph-text type="body">Enzyme compositions comprising additives resulting in a better stability of the enzymes and their preparation.</paragraph-text></list-item><list-item><paragraph-text type="body">Enzyme conjugates being more stabile than the unconjugated enzyme and their preparation.</paragraph-text></list-item></list></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">Carrier-bound or immobilized enzymes are also classified in <class-ref scheme="cpc">C12N11/00</class-ref>.</paragraph-text></section-body></relationship><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Enzymes stabilized by mutation</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref> - <class-ref scheme="cpc">C12N9/94</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Stabilized enzymes are also classified in the most specific subgroup from <class-ref scheme="cpc">C12N9/00</class-ref> - <class-ref scheme="cpc">C12N9/94</class-ref> and in <class-ref scheme="cpc">C12Y</class-ref>.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Stabilisation</paragraph-text></table-column><table-column><paragraph-text type="body">preserving activity in time and/or amount under certain conditions of pH, temperature etc.</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Adduct</paragraph-text></table-column><table-column><paragraph-text type="body">a product of a direct addition of two or more distinct molecules, resulting in a single reaction product containing all atoms of all components</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzyme conjugate</paragraph-text></table-column><table-column><paragraph-text type="body">enzyme covalently bound to one or more disctinct molecules</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2015-03-01"><classification-symbol scheme="cpc">C12N9/98</classification-symbol><definition-title>Preparation of granular or free-flowing enzyme compositions  (<class-ref scheme="cpc">C12N9/96</class-ref> takes precedence)</definition-title><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Preparation of granular or free-flowing enzyme compositions if it is done to stabilise the enzyme </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/96</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Enzymes present in granular or free-flowing enzyme compositions are also classified in the most specific subgroup from <class-ref scheme="cpc">C12N9/00</class-ref> - <class-ref scheme="cpc">C12N9/94</class-ref> and in <class-ref scheme="cpc">C12Y</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2017-08-01"><classification-symbol scheme="cpc">C12N11/00</classification-symbol><definition-title>Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Enzymes or microbial cells that are immobilised or bound to a carrier, and processes for the immobilisation or binding to carriers of enzymes and microbial cells, with the aim of using them as immobilised or carrier-bound enzymes or microbial cells.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Immobilised or carrier-bound peptides or proteins that are not enzymes </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K17/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Processes and methods wherein immobilised or carrier-bound enzymes or microbial cells are used, e.g. fermentative or enzymatic processes for the preparation of compounds or compositions</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Processes and methods wherein immobilised or carrier-bound enzymes or microbial cells are used, e.g. measuring or testing methods involving immobilised or carrier-bound enzymes </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Microorganisms, compositions thereof</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Undifferentiated human, animal or plant cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N5/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">New plants or processes for obtaining them; plant reproduction by tissue culture techniques</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01H</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Biological treatment of water, waste water or sewage </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C02F3/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Apparatus for the use of immobilised or carrier-bound enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12M21/18</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Processes using microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12R</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Y</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The last place rule is applicable, but all information should be given a class. E.g. if a bridging agent is used and the carrier is carbohydrate and both are part of the invention in the application, then classify in both <class-ref scheme="cpc">C12N11/06</class-ref> and <class-ref scheme="cpc">C12N11/10</class-ref>.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Microbial cell</paragraph-text></table-column><table-column><paragraph-text type="body">Microorganisms, including bacteria and other generally unicellular organisms with dimensions beneath the limits of vision which can be propagated and manipulated in a laboratory, including unicellular fungi (including yeasts), microalgae, protozoa and, moreover, human, animal and plant cells.</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2017-08-01"><classification-symbol scheme="cpc">C12N13/00</classification-symbol><definition-title>Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Processes of treating microorganisms or enzymes with electrical or wave energy including magnetic and sound waves.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Microorganisms, compositions thereof</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Undifferentiated human, animal or plant cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N5/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Introduction of foreign genetic material using processes not otherwise provided for</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/87</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">New plants or processes for obtaining them; plant reproduction by tissue culture techniques</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01H</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Gene therapy</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12M35/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Processes using microorganisms</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12R</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Y</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Microorganism</paragraph-text></table-column><table-column><paragraph-text type="body">Bacteria and other generally unicellular organisms with dimensions beneath the limits of vision which can be propagated and manipulated in a laboratory, including viruses and unicellular fungi (including yeasts), algae (including microalgae) and protozoa and, moreover, human, animal and plant cells.</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12N15/00</classification-symbol><definition-title>Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor  (mutants or genetically engineered microorganisms, per se <class-ref scheme="cpc">C12N1/00</class-ref>, <class-ref scheme="cpc">C12N5/00</class-ref>, <class-ref scheme="cpc">C12N7/00</class-ref>; new plants per se <class-ref scheme="cpc">A01H</class-ref>; plant reproduction by tissue culture techniques <class-ref scheme="cpc">A01H4/00</class-ref>; new animals per se <class-ref scheme="cpc">A01K67/00</class-ref>; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy <class-ref scheme="cpc">A61K48/00</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Preparing mutants and screening processes therefor.</paragraph-text><paragraph-text type="body">Processes of fusing two or more cells to each other.</paragraph-text><paragraph-text type="body">Recombinant DNA-technology including:</paragraph-text><list><list-item><paragraph-text type="body">Processes for manipulating genetic material;</paragraph-text></list-item><list-item><paragraph-text type="body">Processes of preparing, isolating and purifying nucleic acids;</paragraph-text></list-item><list-item><paragraph-text type="body">Methods for the introduction of genetic material into cells using vectors or other expression systems, using microencapsulation, using microinjection, and other ways;</paragraph-text></list-item><list-item><paragraph-text type="body">Methods of regulating gene expression;</paragraph-text></list-item><list-item><paragraph-text type="body">Non-coding nucleic acid sequences, e.g. Promoters, operators, enhancers, suppressors, silencers, locus control regions, antisense nucleic acids, and aptamers, used in regulating gene expression or in other recombinant DNA technology related methods. (Non-coding parts of genes are also classified in the subgroup corresponding to the product of the gene in <class-ref scheme="cpc">C07K14/00</class-ref> or <class-ref scheme="cpc">C12N9/00</class-ref>, only if they are part of the invention).</paragraph-text></list-item><list-item><paragraph-text type="body">Operons</paragraph-text></list-item><list-item><paragraph-text type="body">Processes for the preparation of fusion proteins</paragraph-text></list-item></list></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Nucleic acids not used in recombinant technology and their chemical preparation</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Genes and other polynucleotides coding for peptides per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>; <class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Mutants or genetically engineered microorganisms, per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N1/00</class-ref>, <class-ref scheme="cpc">C12N5/00</class-ref>, <class-ref scheme="cpc">C12N7/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Mutants of genetically engineered plant or animal cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N5/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">New plants per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01H</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">New animals per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A01K67/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Classification in <class-ref scheme="cpc">C12N15/00</class-ref> should only be performed in exceptional cases in the absence of a more specific subgroup.</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref>&#160;(and&#160;<class-ref scheme="cpc">C07K14/00</class-ref>) vs.&#160;<class-ref scheme="cpc">C12N15/00</class-ref>:&#160;<class-ref scheme="cpc">C12N9/00</class-ref>&#160;(and&#160;<class-ref scheme="cpc">C07K14/00</class-ref>) stop where&#160;<class-ref scheme="cpc">C12N15/00</class-ref>&#160;begins.&#160;<class-ref scheme="cpc">C12N9/00</class-ref>&#160;(and&#160;<class-ref scheme="cpc">C07K14/00</class-ref>) are only used for the product (the inventive non-coding sequence of a gene) while&#160;<class-ref scheme="cpc">C12N15/00</class-ref>&#160;is used for the use of this product (e.g. a promoter present in a vector for the production of other proteins). Non-coding sequences are only classified in&#160;<class-ref scheme="cpc">C12N9/00</class-ref>&#160;(or&#160;<class-ref scheme="cpc">C07K14/00</class-ref>) if they are (part of) the invention. If the non-coding sequence is just an arbitrary choice from more available sequences it is not classified in&#160;<class-ref scheme="cpc">C12N9/00</class-ref>&#160;(or&#160;<class-ref scheme="cpc">C07K14/00</class-ref>).</paragraph-text><paragraph-text type="subheading">C-Sets classification:</paragraph-text><paragraph-text type="body">In this group, C-Sets (#C12Na) are used. The detailed information about the C-Sets construction and the associated syntax rules are found in the &quot;Special rules of classification&quot; in <class-ref scheme="cpc">C12N15/10</class-ref>. </paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Operon</paragraph-text></table-column><table-column><paragraph-text type="body">A DNA construct containing a cluster of genes under the control of a single regulatory signal or promoter</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/01</classification-symbol><definition-title>Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for generating mutants and their screening processes, without introducing genetic material into the organism (e.g by using chemical mutagens (nitrosoguanidine), specific culture conditions).</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Methods for generating mutants by genetic engineering</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/102</class-ref>, <class-ref scheme="cpc">C12N15/1024</class-ref>, <class-ref scheme="cpc">C12N15/1027</class-ref>, <class-ref scheme="cpc">C12N15/1031</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/02</classification-symbol><definition-title>Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion {(monoclonal antibodies <class-ref scheme="cpc">C07K16/00</class-ref>; apparatus for cell fusion <class-ref scheme="cpc">C12M</class-ref>)}</definition-title><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">See also <class-ref scheme="cpc">C12N5/12</class-ref> through <class-ref scheme="cpc">C12N5/166</class-ref></paragraph-text></section-body></relationship></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/09</classification-symbol><definition-title>Recombinant DNA-technology</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">This subclass will not be used.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12N15/10</classification-symbol><definition-title>Processes for the isolation, preparation or purification of DNA or RNA  (chemical preparation of DNA or RNA <class-ref scheme="cpc">C07H21/00</class-ref>; preparation of non-structural polynucleotides from microorganisms or with enzymes <class-ref scheme="cpc">C12P19/34</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods concerning the cloning, recombination, and generation of genetic material (DNA, RNA) by recombinant DNA technology; genetic engineering.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Host cells which are genetically engineered</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N1/20</class-ref>, <class-ref scheme="cpc">C12N5/00</class-ref>, <class-ref scheme="cpc">C12N7/00</class-ref>, <class-ref scheme="cpc">C12N15/82</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Encoding nucleic acids, i.e. genes; Enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Isolation of nucleic acids from host cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1003</class-ref>, <class-ref scheme="cpc">C12N15/1006</class-ref>, <class-ref scheme="cpc">C12N15/101</class-ref>, <class-ref scheme="cpc">C12N15/1013</class-ref>, <class-ref scheme="cpc">C12N15/1017</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having biological activity, modulating the expression of genes (e.g. siRNA, miRNA,..; aptamers</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/11</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical preparation of DNA or RNA not used in recombinant technology</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Encoding nucleic acids, i.e. genes; Polypeptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Sequences of promoter, enhancer, intron, exon, IRES, IME are classified according to their corresponding gene sequence, e.g. polypeptide/enzyme</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C12N15/11</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation of non-structural polynucleotides from microorganisms or with enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P19/34</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleic acids used in diagnostics; Assays and products for analysing or detecting nucleic acids </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleic acid assays and products for analysing or detecting viruses or bacteriophages</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/70</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleic acids libraries</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="subheading">Combination sets (C-Sets):</paragraph-text><paragraph-text type="subheading">C-Sets statement : #C12Na</paragraph-text><list><list-item><paragraph-text type="body">In groups&#160;<class-ref scheme="cpc">C12N15/10</class-ref> and its lower subgroups, DNA or RNA isolation/preparation processes are classified in the form of C-Sets.</paragraph-text></list-item><list-item><paragraph-text type="body">In these C-Sets, the base symbol, representing DNA or RNA isolation/preparation processes (or method), is taken from the groups <class-ref scheme="cpc">C12N15/10</class-ref> - <class-ref scheme="cpc">C12N15/1096</class-ref>, whereas the subsequent symbol(s), representing the essential non-trivial technical feature(s) of the method, is (are) taken from the Indexing Codes under <class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Orthogonal symbols <class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref> are only used as subsequent symbols in C-Sets and should not be allocated as single symbols.</paragraph-text></list-item><list-item><paragraph-text type="body">In the C-set, only the essential technical features of the invention, which are non-trivial and differentiate them from the prior art, are to be represented using appropriate Indexing Codes <class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref>. </paragraph-text></list-item><list-item><paragraph-text type="body">All indexing codes from groups&#160;<class-ref scheme="cpc">C12Q2500/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12Q2565/634</class-ref>&#160;are to be used in the context literally expressed in the phrase ascribed to the code, i.e. the use of an indexing code is neither restricted by its hierarchical position in a group nor by the definition of the group in which the code is found.</paragraph-text></list-item></list><paragraph-text type="subheading">C-Sets syntax rules:</paragraph-text><list><list-item><paragraph-text type="body">Each C-Set shall contain at least two symbols.</paragraph-text></list-item><list-item><paragraph-text type="body">Duplicate symbols are not allowed in these C-Sets. Multiple subsequent symbols from <class-ref scheme="cpc">C12Q2500/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12Q2565/634</class-ref>,&#160;if fit, can be used as C-Sets. </paragraph-text></list-item><list-item><paragraph-text type="body">The order of symbols in the C-Sets is relevant as it reflects the methods or process as a base symbol and the specific components of cell culture medium as a subsequent symbol, which are displayed in alphanumerical order. </paragraph-text></list-item></list><paragraph-text type="subheading">C-Sets examples:</paragraph-text><list><list-item><paragraph-text type="body">#C12Na: A method of directed molecular evolution (<class-ref scheme="cpc">C12N15/1058</class-ref>) comprising incorporating random nucleotide sequences (<class-ref scheme="cpc">C12Q2525/179</class-ref>) by primer extension (<class-ref scheme="cpc">C12Q2533/101</class-ref>) of oligonucleotides comprising a modified backbone (<class-ref scheme="cpc">C12Q2525/113</class-ref>) is classified as (<class-ref scheme="cpc">C12N15/1058</class-ref>, <class-ref scheme="cpc">C12Q2525/113</class-ref>, <class-ref scheme="cpc">C12Q2525/179</class-ref>, <class-ref scheme="cpc">C12Q2533/101</class-ref>).</paragraph-text></list-item><list-item><paragraph-text type="body">#C12Na: A method of isolating genomic DNA by ion exchange (<class-ref scheme="cpc">C12N15/101</class-ref>) for the purpose of massive parallel sequencing (<class-ref scheme="cpc">C12Q2535/122</class-ref>) using a heat treatment (<class-ref scheme="cpc">C12Q2527/101</class-ref>) is classified as (<class-ref scheme="cpc">C12N15/101</class-ref>, <class-ref scheme="cpc">C12Q2527/101</class-ref>, <class-ref scheme="cpc">C12Q2535/122</class-ref>).</paragraph-text></list-item></list></section-body></special-rules><synonyms-keywords><section-title>Synonyms and Keywords</section-title><abbreviations>
<paragraph-text type="preamble">In patent documents, the following abbreviations are often used:</paragraph-text>
<table>
<table-row><table-column><paragraph-text type="body">IRES</paragraph-text></table-column><table-column><paragraph-text type="body">Internal Ribosome Entry Site</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">IME</paragraph-text></table-column><table-column><paragraph-text type="body">Intron Mediated Enhancement of gene Expression</paragraph-text></table-column></table-row></table>
</abbreviations></synonyms-keywords></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1003</classification-symbol><definition-title>{Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for the isolation of nucleic acids e.g. DNA, RNA, plasmids, vectors, genomic DNA, genomic RNA) from microorganisms, viruses and plant origin.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Host cells which are genetically engineered</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N1/20</class-ref>, <class-ref scheme="cpc">C12N5/00</class-ref>, <class-ref scheme="cpc">C12N7/00</class-ref>, <class-ref scheme="cpc">C12N15/82</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical, physical, or physico-chemical processes in general; Their relevant apparatus</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01J19/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Solid sorbent composition or filter aid compositions per se, suitable for the isolation of nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01J20/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Ion exchange material per se, suitable for the isolation of nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01J39/00</class-ref>, <class-ref scheme="cpc">B01J41/00</class-ref>, <class-ref scheme="cpc">B01J43/00</class-ref>, <class-ref scheme="cpc">B01J45/00</class-ref>, <class-ref scheme="cpc">B01J47/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Any apparatuses per se, suitable for use in a process of extracting or isolating nucleic acids from microorganisms, viral or plant origin</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01L3/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Apparatuses for enzymology or microbiology per se, suitable for the extraction, isolation and preparation of nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12M1/00</class-ref>, <class-ref scheme="cpc">C12M3/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1006</classification-symbol><definition-title>{by means of a solid support carrier, e.g. particles, polymers}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for the isolation of nucleic acids using a solid phase, e.g. non-magnetic beads.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Solid support carrier per se, suitable for carrying out the methods</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C08</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/101</classification-symbol><definition-title>{by chromatography, e.g. electrophoresis, ion-exchange, reverse phase}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for the isolation of nucleic acids by chromatography, binding the nucleic acid onto a column, washing and eluting the nucleic acid.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Chromatographic material per se, suitable for carrying out the methods</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N30/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1013</classification-symbol><definition-title>{by using magnetic beads}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for the isolation of nucleic acids by chromatography, binding the nucleic acid to para-, ferro- or dia-magnetic beads, e.g. Dynabeads;</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Magnetic material per se, suitable for carrying out the methods</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B03C1/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Magnets or magnetic bodies characterised by the magnetic material therefor</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">H01F1/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1017</classification-symbol><definition-title>{by filtration, e.g. using filters, frits, membranes}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for the isolation of nucleic acids by chromatography using filter, frits, membranes.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Filter material, frits and membranes per se, suitable for carrying out the methods</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">B01D</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item date-revised="2016-11-01"><classification-symbol scheme="cpc">C12N15/102</classification-symbol><definition-title>{Mutagenizing nucleic acids}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General in vitro method of mutagenesis of nucleic acid by recombinant DNA technology, inserting/deleting/replacing nucleotides e.g. using oligonucleotides and site directed mutagenesis, error prone PCR, splicing by overlap extension.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">DNA shuffling</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1027</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Oligonucleotide assembly</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1031</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Signature-tagged-mutagenesis (STM)</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1065</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/10</class-ref> group.</paragraph-text></section-body></special-rules><synonyms-keywords><section-title>Synonyms and Keywords</section-title><abbreviations>
<paragraph-text type="preamble">In patent documents, the following abbreviations are often used:</paragraph-text>
<table>
<table-row><table-column><paragraph-text type="body">SOE</paragraph-text></table-column><table-column><paragraph-text type="body">Splicing by Overlap Extension</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">PCR</paragraph-text></table-column><table-column><paragraph-text type="body">Polymerase Chain Reaction</paragraph-text></table-column></table-row></table>
</abbreviations></synonyms-keywords></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1024</classification-symbol><definition-title>{In vivo mutagenesis using high mutation rate &quot;mutator&quot; host strains by inserting genetic material, e.g. encoding an error prone polymerase, disrupting a gene for mismatch repair}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">In vivo method of mutagenesis of nucleic acid by recombinant DNA technology, e.g. inserting/deleting/replacing nucleotides by introducing genetic material into the host cell, or disrupting the mismatch repair mechanism of the cell.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">In vitro mutagenesis technique </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/102</class-ref>, <class-ref scheme="cpc">C12N15/1027</class-ref>, <class-ref scheme="cpc">C12N15/1031</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/10</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2016-11-01"><classification-symbol scheme="cpc">C12N15/1027</classification-symbol><definition-title>{by DNA shuffling, e.g. RSR, STEP, RPR}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Mutagenesis by combined DNA shuffling;</paragraph-text></list-item><list-item><paragraph-text type="body">DNA sequence evolution by sexual PCR;</paragraph-text></list-item><list-item><paragraph-text type="body">Degenerate oligonucleotide gene shuffling and random drift mutagenesis.</paragraph-text></list-item></list></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">In vitro mutagenesis by DNA fragment assembly</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1031</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/10</class-ref> group.</paragraph-text></section-body></special-rules><synonyms-keywords><section-title>Synonyms and Keywords</section-title><abbreviations>
<paragraph-text type="preamble">In patent documents, the following abbreviations are often used:</paragraph-text>
<table>
<table-row><table-column><paragraph-text type="body">RSR</paragraph-text></table-column><table-column><paragraph-text type="body">Recursive Sequence Recombination</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">StEP</paragraph-text></table-column><table-column><paragraph-text type="body">Staggered Extension Process</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">PRP</paragraph-text></table-column><table-column><paragraph-text type="body">Random-Priming in vitro Recombination</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">ITCHY</paragraph-text></table-column><table-column><paragraph-text type="body">Incremental Truncation for the Creation of Hybrid enzymes</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">DOGS</paragraph-text></table-column><table-column><paragraph-text type="body">Degenerate Oligonucleotide Gene Shuffling</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">RNDM</paragraph-text></table-column><table-column><paragraph-text type="body">Random Drift Mutagenesis</paragraph-text></table-column></table-row></table>
</abbreviations></synonyms-keywords></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1031</classification-symbol><definition-title>{mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Preparation of mutated genes by polynucleotide fragment assembly, e.g. assembly of genes using single-stranded oligonucleotides.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">DNA shuffling</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1027</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/10</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2019-02-01"><classification-symbol scheme="cpc">C12N15/1034</classification-symbol><definition-title>{Isolating an individual clone by screening libraries}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General method for screening libraries and isolating an individual clone in which the preparation of the library is not an essential technical feature.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Preparation of the library</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1093</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Libraries per se </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B40/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G16B35/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">In silico combinatorial chemistry</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G16C20/60</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/10</class-ref> group.</paragraph-text><paragraph-text type="body">Classification in <class-ref scheme="cpc">C12N15/1034</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12N15/1093</class-ref> takes precedence over classification in <class-ref scheme="cpc">C40B</class-ref>. That is to say <class-ref scheme="cpc">C40B</class-ref> is of secondary importance and documents must always be classified in <class-ref scheme="cpc">C12N15/1034</class-ref> and subgroups. A classification symbol from <class-ref scheme="cpc">C40B</class-ref> may be given in addition. (N.B. <class-ref scheme="cpc">C40B</class-ref> is never used for search in this field).</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1037</classification-symbol><definition-title>{Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Preparation or screening of peptide libraries displayed by microorganism, cellular peptide display, e.g. phage display, E. coli display, yeast display, eukaryotic cell display.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Libraries per se contained in or displayed by microorganism</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B40/02</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2016-11-01"><classification-symbol scheme="cpc">C12N15/1041</classification-symbol><definition-title>{Ribosome/Polysome display, e.g. SPERT, ARM}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Method for selecting high-affinity polypeptide ligands that specifically bind target molecules by ribosome/polysome display.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">mRNA display</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1062</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">DNA display</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1068</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules><synonyms-keywords><section-title>Synonyms and Keywords</section-title><abbreviations>
<paragraph-text type="preamble">In patent documents, the following abbreviations are often used:</paragraph-text>
<table>
<table-row><table-column><paragraph-text type="body">SPERT</paragraph-text></table-column><table-column><paragraph-text type="body">Systematic Polypeptide Evolution by Reverse Translation</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">ARM</paragraph-text></table-column><table-column><paragraph-text type="body">Antibody-Ribosome-mRNA</paragraph-text></table-column></table-row></table>
</abbreviations></synonyms-keywords></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1044</classification-symbol><definition-title>{Preparation or screening of libraries displayed on scaffold proteins}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Preparation or screening a library of polypeptides comprising a scaffold-based molecule comprising loop domains, e.g. constructing or screening a library of a scaffold-based proteins which are derived from a stability enhanced consensus sequence of a fibronectin type III (FN3) domain incorporating randomized codons in order to produce polypeptide variants.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Library of scaffold based polypeptides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B40/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1048</classification-symbol><definition-title>{SELEX}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Method of aptamer selection, screening of DNA/RNA aptamers by systematic evolution of ligands by exponential amplification (SELEX);</paragraph-text></list-item><list-item><paragraph-text type="body">genomic SELEX;</paragraph-text></list-item><list-item><paragraph-text type="body">whole cell SELEX.</paragraph-text></list-item></list></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Aptamers per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/115</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Peptide aptamers, i.e. build from aminoacids rather than nucleotidesamino acids rather than nucleotides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Library of aptamers</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B40/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">SELEX</paragraph-text></table-column><table-column><paragraph-text type="body">Systematic Evolution of Ligands by EXponential amplification</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Aptamers</paragraph-text></table-column><table-column><paragraph-text type="body">Nucleic acid ligands</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1051</classification-symbol><definition-title>{Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Method of creating or screening a library of gene sequences by gene-trap cloning, isolation of gene sequences by gene-trap cloning, e.g. exons, introns, promoters, enhancer, signal sequences, IRES-, IME-sequences.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Preparation and screening expression libraries using reporter assays</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1086</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Trap vectors per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/70</class-ref> - <class-ref scheme="cpc">C12N15/82</class-ref>, <class-ref scheme="cpc">C12N15/85</class-ref> - <class-ref scheme="cpc">C12N15/86</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/10</class-ref> and <class-ref scheme="cpc">C12N15/1034</class-ref> groups.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">IRES</paragraph-text></table-column><table-column><paragraph-text type="body">Internal Ribosome Entry Site</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">IME</paragraph-text></table-column><table-column><paragraph-text type="body">sequence responsible for Intron Mediated Enhancement of gene expression</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1055</classification-symbol><definition-title>{Protein x Protein interaction, e.g. two hybrid selection}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Preparation or screening libraries and isolating an individual clone which is involved in protein x protein interaction which involves gene expression, expression of a reporter gene e.g. in vivo library-versus-library selection of optimized protein-protein interactions, phage-based systems to select multiple protein-protein interactions simultaneously from combinatorial libraries,</paragraph-text></list-item><list-item><paragraph-text type="body">Yeast three-hybrid system,</paragraph-text></list-item><list-item><paragraph-text type="body">Three hybrid based screening assays using mammalian cells.</paragraph-text></list-item></list></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Preparation or screening expression libraries, e.g. reporter assays</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1086</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Methods of identifying protein-protein interactions in protein mixtures</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G01N33/6845</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1058</classification-symbol><definition-title>{Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Method for the preparation, screening and isolation of gene sequences by a methods of directed molecular evolution using the modified polynucleotide libraries, e.g. cellular transformation, directed evolution, and screening methods for creating novel transgenic organisms having desirable properties, method of screening gene libraries derived from a mixed population of organisms for a bioactivity of biomolecule of interest.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1062</classification-symbol><definition-title>{mRNA-Display, e.g. polypeptide and encoding template are connected covalently}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Linking phenotype (polypeptide) covalently to mRNA (genotype) and screening libraries of such polypeptide-mRNA-display molecules for activity to identify single library member (polynucleotide sequence) that bind with a target molecule.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Polypeptide non-covalently bound to mRNA</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1075</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Cellular display</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1037</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Ribosome/Polysome display</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1041</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">DNA display</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1075</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1065</classification-symbol><definition-title>{Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Method of preparation or screening of tagged libraries;</paragraph-text></list-item><list-item><paragraph-text type="body">Method of tracking, identifying, and/or sorting classes or subpopulations of molecules by the use of (oligonucleotide) tags;</paragraph-text></list-item><list-item><paragraph-text type="body">Method whereby a molecular tag is put on a gene, transcript;</paragraph-text></list-item><list-item><paragraph-text type="body">Tag-creating DNA library, tagged microorganism by signature-tagged-mutagenesis (STM), e.g. gene identification signature (GIS) analysis, indexed library of cells, high throughput method for identification of sequence tags, tagged epitope protein transposable element, identification of transposon insertions within a transcribed portion of a gene of interest.</paragraph-text></list-item></list></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Library of templated molecules covalently or non-covalently linked to the encoded nuclei acid template, library of templated molecules linked to identifier oligonucleotides which have participated in the synthesis of said templated molecules.</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1068</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">RBS-assay</paragraph-text></table-column><table-column><paragraph-text type="body">Replica Barcode Selection assay</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">GIS</paragraph-text></table-column><table-column><paragraph-text type="body">Gene Identification Signature</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">STM</paragraph-text></table-column><table-column><paragraph-text type="body">Signature-Tagged-Mutagenesis</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1068</classification-symbol><definition-title>{Template (nucleic acid) mediated chemical library synthesis, e.g. chemical and enzymatical DNA-templated organic molecule synthesis, libraries prepared by non ribosomal polypeptide synthesis [NRPS], DNA/RNA-polymerase mediated polypeptide synthesis}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Methods and compositions for performing ordered multi-step synthesis by nucleic acid template mediated chemistry;</paragraph-text></list-item><list-item><paragraph-text type="body">Methods of synthesizing libraries of molecules comprising a functional moiety which is operatively linked to an encoding oligonucleotide;</paragraph-text></list-item><list-item><paragraph-text type="body">Library of templated molecules covalently or non-covalently linked to the encoded nuclei acid template;</paragraph-text></list-item><list-item><paragraph-text type="body">Library of templated molecules linked to identifier oligonucleotides which have participated in the synthesis of said templated molecules.</paragraph-text></list-item></list></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Libraries of templated molecules per se linked to their encoded nucleic acid templates</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B40/06</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1072</classification-symbol><definition-title>{Differential gene expression library synthesis, e.g. subtracted libraries, differential screening}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Preparation or screening at least two different libraries for obtaining or amplifying a polynucleotide (a tester-specific polynucleotide), in which an amount existing in a sample (tester) is larger than the amount existing in another sample (driver);</paragraph-text></list-item><list-item><paragraph-text type="body">Method to identify differentially expressed nucleotide sequences; subtractive hybridization process of enrichment of specific sequences from nucleic acid directory corresponding to a test directory; selective tagging of nucleic acids.</paragraph-text></list-item></list></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1075</classification-symbol><definition-title>{by coupling phenotype to genotype, not provided for in other groups of this subclass}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">In vitro method of preparation or screening of libraries in cell-free compartmentalization systems (IVC), e.g. screening libraries prepared in emulsions (water in oil), droplets in contact with oil; directed evolution of polypeptide/enzyme (peptide display library) by in vitro compartmentalization;</paragraph-text><paragraph-text type="body">covalent or non-covalent DNA-display.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Cellular display</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1037</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Ribosome/Polysome display</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1041</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">mRNA display</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1062</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Library of templated molecules covalently or non-covalently linked to the encoded nuclei acid template, library of templated molecules linked to identifier oligonucleotides which have participated in the synthesis of said templated molecules</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1068</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Libraries per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Library of templated molecules covalently or non-covalently linked to the encoded nuclei acid template</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1068</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">DNA display</paragraph-text></table-column><table-column><paragraph-text type="body">Polypeptide is covalently or non-covalently bound to DNA</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">IVC</paragraph-text></table-column><table-column><paragraph-text type="body">In vitro cell-free compartmentalization systems</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1079</classification-symbol><definition-title>{Screening libraries by altering the phenotype or phenotypic trait of the host  (reporter assays <class-ref scheme="cpc">C12N15/1086</class-ref>)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Method of identifying nuclei acids that contributes to cell phenotype or phenotypic traits, e.g. method for the identification of genes that are essential for the maintenance of specific cell phenotypes.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1082</classification-symbol><definition-title>{Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Method of identifying nuclei acids by preparation or screening a genome library in which at least one nucleic acid was stable integrated e.g. using HR, site-specific recombination, transposons, viral vectors, into the genome of the host cell, e.g. using methods for site-specifically integrating at least one first nucleic acid into a genome of at least one cell.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">HR</paragraph-text></table-column><table-column><paragraph-text type="body">Homologous Recombination</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1086</classification-symbol><definition-title>{Preparation or screening of expression libraries, e.g. reporter assays}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Method of identifying nuclei acids by preparation or screening a library of nucleic acids using reporter assays, wherein the reporter confers a selectable phenotype on cells, e.g. lacZ, GFP, YFP, Luc.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Gene-trapping</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1051</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Libraries per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">lacZ</paragraph-text></table-column><table-column><paragraph-text type="body">Beta-galactosidase</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">GFP</paragraph-text></table-column><table-column><paragraph-text type="body">Green Fluorescent Protein</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">YFP</paragraph-text></table-column><table-column><paragraph-text type="body">Yellow Fluorescent Protein</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Luc</paragraph-text></table-column><table-column><paragraph-text type="body">Luciferase</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2019-02-01"><classification-symbol scheme="cpc">C12N15/1089</classification-symbol><definition-title>{Design, preparation, screening or analysis of libraries using computer algorithms}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Method of identifying nuclei acids by preparation or screening a library of nucleic acids in which at least one step comprises the use of a computer algorithm or an in silico step e.g. to align nucleotide sequences, in silico recombination techniques by designing oligonucleotides for regulated recombination.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Libraries per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G16B35/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">In silico combinatorial chemistry</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">G16C20/60</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1093</classification-symbol><definition-title>{General methods of preparing gene libraries, not provided for in other subgroups}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Method of identifying nuclei acids by preparation or screening a library of nucleic acids/host cells not provided for in other subgroups.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/1034</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1096</classification-symbol><definition-title>{cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Method for preparing cDNA by reverse translation of RNA, e.g. preparation and cloning DNA into a vector in which the reverse transcription is an essential feature of the process.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/10</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2018-01-01"><classification-symbol scheme="cpc">C12N15/11</classification-symbol><definition-title>DNA or RNA fragments; Modified forms thereof  (DNA or RNA not used in recombinant technology, <class-ref scheme="cpc">C07H21/00</class-ref>); {Non-coding nucleic acids having a biological activity}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Natural or synthetic nucleic acids used in biotechnology and genetic engineering.</paragraph-text><paragraph-text type="body">Subgroups <class-ref scheme="cpc">C12N15/11</class-ref> - <class-ref scheme="cpc">C12N15/117</class-ref> also cover the use of non-coding nucleic acids as active ingredients medicinal preparations</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">DNA or RNA not used in recombinant technology.</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleotides and nucleosides per se and modified forms thereof.</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Encoding nucleic acids, i.e. genes, with the exception of operons.</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Methods for isolating, preparing or purifying nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Pharmaceutical compositions comprising nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K31/7088</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, e.g. gene therapy </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical preparation of DNA or RNA not used in recombinant technology</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Encoding nucleic acids, i.e. genes </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>; <class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation of non-structural polynucleotides from microorganisms or with enzymes </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P19/34</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleic acids use in diagnostics; probes; primers</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleic acid libraries</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">No distinction is made between &apos;invention&apos; and &apos;additional&apos; information. All technical features belonging to the &apos;invention&apos; and all those exemplified in the document are classified. The allocation of additional information symbols, where possible, is mandatory.</paragraph-text><paragraph-text type="body">Classification is made in all appropriate places, unless otherwise specified.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">DNA</paragraph-text></table-column><table-column><paragraph-text type="body">DeoxyriboNucleic Acid</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">RNA</paragraph-text></table-column><table-column><paragraph-text type="body">RiboNucleic Acid</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2017-08-01"><classification-symbol scheme="cpc">C12N15/111</classification-symbol><definition-title>{General methods applicable to biologically active non-coding nucleic acids}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods and processes of general interest for one or more class(es) of non-coding nucleic acids.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">The products per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/11</class-ref>, <class-ref scheme="cpc">C12N15/113</class-ref> - <class-ref scheme="cpc">C12N15/117</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Methods for isolating, preparing or purifying nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Pharmaceutical compositions comprising nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K31/7088</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, e.g. gene therapy </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical preparation of DNA or RNA not used in recombinant technology</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Encoding nucleic acids, i.e. genes </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation of non-structural polynucleotides from microorganisms or with enzymes </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P19/34</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleic acids use in diagnostics; probes; primers</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleic acid libraries</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The methods or processes should always be further defined by the relevant codes of the <class-ref scheme="cpc">C12N2320/00</class-ref> indexing scheme.</paragraph-text><paragraph-text type="body">Methods or processes which are obviously state of the art are not classified</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2017-08-01"><classification-symbol scheme="cpc">C12N15/113</classification-symbol><definition-title>Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing  (when used in plants <class-ref scheme="cpc">C12N15/8218</class-ref>)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Nucleic acids having a direct effect on the expression of a gene or the transcription of its messenger such as Antisense nucleic acids, Catalytic nucleic acids, e.g. ribozymes, Triplex-forming oligonucleotides, Decoys, Nucleic acids used in gene silencing or RNA interference, or MicroRNAs.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body"> Regulatory sequences being part of genes, e.g. promoters or terminators</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/63</class-ref> - <class-ref scheme="cpc">C12N15/90</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Their use in plants</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/8218</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Encoding nucleic acids, i.e. genes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body"> Probes and primers</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Methods for isolating, preparing or purifying nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Pharmaceutical compositions comprising nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K31/7088</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, e.g. gene therapy </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical preparation of DNA or RNA not used in recombinant technology</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H21/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Encoding nucleic acids, i.e. genes </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K14/00</class-ref>; <class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Preparation of non-structural polynucleotides from microorganisms or with enzymes </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12P19/34</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleic acids use in diagnostics; probes; primers</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Nucleic acid libraries</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">In addition to the Rules already outlined for <class-ref scheme="cpc">C12N15/11</class-ref>, use of the <class-ref scheme="cpc">C12N2310/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12N2330/00</class-ref> indexing schemes is made.</paragraph-text><paragraph-text type="body">In this group and its subgroups classification is made according to the origin and nature of the target and should follow the categorisation made in <class-ref scheme="cpc">C07K14/00</class-ref>. Additional help can be found in the MeSH database of the NCBI</paragraph-text><paragraph-text type="body">(www.ncbi.nlm.nih.gov/mesh ).</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Antisense nucleic acid</paragraph-text></table-column><table-column><paragraph-text type="body">DNA or RNA composed of the complementary sequence to the target DNA/RNA</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Ribozyme</paragraph-text></table-column><table-column><paragraph-text type="body">Nucleic acid with a catalytic activity</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">MicroRNA</paragraph-text></table-column><table-column><paragraph-text type="body">Small double-stranded RNA (21-25 nucleotides) generated from a precursor transcript by cleavage with Dicer</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Decoy oligonucleotide</paragraph-text></table-column><table-column><paragraph-text type="body">A (double-stranded) oligonucleotide comprising a binding-site for a protein</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Gene silencing</paragraph-text></table-column><table-column><paragraph-text type="body">Interruption or suppression of the expression of a gene at transcriptional or translational levels.</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms><synonyms-keywords><section-title>Synonyms and Keywords</section-title><abbreviations>
<paragraph-text type="preamble">In patent documents, the following abbreviations are often used:</paragraph-text>
<table>
<table-row><table-column><paragraph-text type="body">miRNA</paragraph-text></table-column><table-column><paragraph-text type="body">MicroRNA</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">TFO, triple helix</paragraph-text></table-column><table-column><paragraph-text type="body">Triplex-forming oligonucleotide</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">siRNA</paragraph-text></table-column><table-column><paragraph-text type="body">Small interfering RNA</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">shRNA</paragraph-text></table-column><table-column><paragraph-text type="body">short hairpin RNA</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">RNA interference</paragraph-text></table-column><table-column><paragraph-text type="body">RNAi, gene interference, gene silencing, RNA silencing, cosuppression, co-suppression, post-transcriptional gene silencing, PTGS</paragraph-text></table-column></table-row></table>
</abbreviations></synonyms-keywords></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1135</classification-symbol><definition-title>{against oncogenes or tumor suppressor genes}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Non-coding nucleic acids directed against targets directly involved in the oncogenic processes, e.g. when their expression or activity is de-regulated.</paragraph-text></section-body></definition-statement><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Oncogenes</paragraph-text></table-column><table-column><paragraph-text type="body">Genes whose gain-of-function alterations lead to neoplastic cell transformation</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Tumour suppressor genes</paragraph-text></table-column><table-column><paragraph-text type="body">Genes that inhibit formation and/or development of the tumorigenic phenotype</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2019-01-01"><classification-symbol scheme="cpc">C12N15/1137</classification-symbol><definition-title>{against enzymes  (viral enzymes <class-ref scheme="cpc">C12N15/1131</class-ref>; receptors <class-ref scheme="cpc">C12N15/1138</class-ref>)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Non-coding nucleic acids directed to nucleic acids encoding proteins with an enzymatic activity.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Viral enzymes</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1131</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Receptors having also an enzymatic domain</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1138</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The enzyme(s) targeted are further specified by using the appropriate symbol(s) from the <class-ref scheme="cpc">C12Y</class-ref> scheme.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/1138</classification-symbol><definition-title>{against receptors or cell surface proteins}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">Nucleic acids targeting receptors, i.e. membrane-embedded proteins transmitting a signal after binding of their ligand(s), including nuclear receptors.</paragraph-text></list-item><list-item><paragraph-text type="body">Nucleic acids targeting any protein normally present on the surface of a cell, e.g. ion channels.</paragraph-text></list-item></list></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Nucleic acids against binding proteins other than receptors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/113</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item date-revised="2016-11-01"><classification-symbol scheme="cpc">C12N15/115</classification-symbol><definition-title>Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Peptide aptamers, i.e. built from aminoacids rather than nucleotides.</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07K</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Nucleic acid libraries</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C40B10/00</class-ref>, <class-ref scheme="cpc">C40B40/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><list><list-item><paragraph-text type="body">The corresponding Indexing Code should always be given in addition to the class.</paragraph-text></list-item><list-item><paragraph-text type="body">Known aptamers linked to another entity as regulatory domain should be classified in the group corresponding to said entity and the Indexing Code for the aptamer added.</paragraph-text></list-item></list></section-body></special-rules><synonyms-keywords><section-title>Synonyms and Keywords</section-title><abbreviations>
<paragraph-text type="preamble">In patent documents, the following abbreviations are often used:</paragraph-text>
<table>
<table-row><table-column><paragraph-text type="body">Aptamer</paragraph-text></table-column><table-column><paragraph-text type="body">Nucleic acid ligand, NAL</paragraph-text></table-column></table-row></table>
</abbreviations></synonyms-keywords></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/117</classification-symbol><definition-title>Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Non-coding nucleic acids having a direct impact on the immune system.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Adjuvants containing nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K2039/55561</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The corresponding Indexing Code should always be given in addition to the class.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2015-03-01"><classification-symbol scheme="cpc">C12N15/52</classification-symbol><definition-title>Genes encoding for enzymes or proenzymes</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Operons: DNA constructs containing a cluster of genes under the control of a single regulatory signal or promoter.</paragraph-text><paragraph-text type="body">Groups of genes for enzymes providing an organism with the ability to synthesize a specific compound or compounds (e.g. synthetic (partial) pathways)</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Genes coding for single enzymes </paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The genes present in the operon are also classified in <class-ref scheme="cpc">C12N9/00</class-ref> and subgroups and in <class-ref scheme="cpc">C12Y</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2017-05-01"><classification-symbol scheme="cpc">C12N15/62</classification-symbol><definition-title>DNA sequences coding for fusion proteins</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods to produce a fusion protein by recombinant DNA technology</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Fusion proteins per se and the nucleic acids encoding them.</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C07K2319/00</class-ref>, <class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C07K16/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">This group covers only documents in which emphasis is given on the method for the preparation of fusion proteins.</paragraph-text><paragraph-text type="body">The products of the method are also classified in the groups for the individual proteins being part of the fusion protein.</paragraph-text><paragraph-text type="body">The documents have further to be given an Indexing Code for fusion proteins: <class-ref scheme="cpc">C07K2319/00</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2017-05-01"><classification-symbol scheme="cpc">C12N15/625</classification-symbol><definition-title>{containing a sequence coding for a signal sequence}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods for producing, by recombinant DNA technology, a fusion protein in which one of the fused polypeptides consists of a signal sequence with or without (part of) its mature protein.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Fusion proteins per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N9/00</class-ref>, <class-ref scheme="cpc">C07K2319/00</class-ref>, <class-ref scheme="cpc">C07K14/00</class-ref>, <class-ref scheme="cpc">C07K16/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">This group covers only documents in which emphasis is given on the method for the preparation of fusion proteins containing a signal sequence.</paragraph-text><paragraph-text type="body">The products of the method are also classified in the groups for the individual proteins being part of the fusion protein. This includes classification into the group for the polypeptide from which the signal sequence has been derived</paragraph-text><paragraph-text type="body">The document has further to be given an Indexing Code for fusion proteins: <class-ref scheme="cpc">C07K2319/00</class-ref>.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Fusion protein</paragraph-text></table-column><table-column><paragraph-text type="body">A polypeptide consisting of (parts of) two or more different proteins covalently linked to each other by a peptide bond</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Signal sequence</paragraph-text></table-column><table-column><paragraph-text type="body">A 3-60 amino acid long peptide that directs the transport of the protein that is attached to it</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/63</classification-symbol><definition-title>Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General method for regulating (enhancing, inhibiting) the gene expression by modifying the operator, enhancer or promoter dependent transcription of the messenger RNA.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Ribosome mediated translational regulation of gene expression</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/67</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/00</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/635</classification-symbol><definition-title>{Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General method for regulating (enhancing, inhibiting) the gene expression by modifying/regulating the repressor or inducer mediated transcription of the messenger RNA.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Ribosome mediated translational regulation of gene expression</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/67</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/00</class-ref> group.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12N15/64</classification-symbol><definition-title>General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General methods for generating vectors for use in recombinant technology i.e. cloning methods for preparing a general vector. A general vector is to be understood as being one which is independent of the origin of replication. Methods for specifically preparing e.g. a plant, viral or mammalian vector, wherein the method of preparation is restricted to and applicable only in e.g. a plant, virus or mammal are classified in their corresponding vector group.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Bacterial vectors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/70</class-ref>, <class-ref scheme="cpc">C12N15/71</class-ref>, <class-ref scheme="cpc">C12N15/72</class-ref>, <class-ref scheme="cpc">C12N15/73</class-ref>, <class-ref scheme="cpc">C12N15/74</class-ref>, <class-ref scheme="cpc">C12N15/75</class-ref>, <class-ref scheme="cpc">C12N15/76</class-ref>, <class-ref scheme="cpc">C12N15/77</class-ref>, <class-ref scheme="cpc">C12N15/78</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Eukaryotic vectors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/79</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Fungal vectors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/80</class-ref>, <class-ref scheme="cpc">C12N15/81</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Plant vectors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/82</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Animal vectors</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/85</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Viral vectors for animal cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/86</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="subheading">Combination sets (C-Sets):</paragraph-text><paragraph-text type="subheading">C-Sets statement : #C12Nb</paragraph-text><list><list-item><paragraph-text type="body">In groups&#160;<class-ref scheme="cpc">C12N15/64</class-ref> - <class-ref scheme="cpc">C12N15/66</class-ref>, methods for preparing vectors are classified in the form of C-Sets.</paragraph-text></list-item><list-item><paragraph-text type="body">In these C-Sets, the base symbol, representing methods for preparing vectors, is taken from the groups <class-ref scheme="cpc">C12N15/64</class-ref> - <class-ref scheme="cpc">C12N15/66</class-ref>, whereas the subsequent symbols, representing the feature(s) of the methods, is/are taken from the Indexing Codes under <class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref>.</paragraph-text></list-item><list-item><paragraph-text type="body">Orthogonal symbols <class-ref scheme="cpc">C12Q2500/00</class-ref> - <class-ref scheme="cpc">C12Q2565/634</class-ref> are only used as subsequent symbols in C-Sets and should not be allocated as single symbols.</paragraph-text></list-item><list-item><paragraph-text type="body">In the C-set, only the essential technical features of the invention, which differentiate it from the prior art, are to be represented.</paragraph-text></list-item><list-item><paragraph-text type="body">All indexing codes from groups&#160;<class-ref scheme="cpc">C12Q2500/00</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12Q2565/634</class-ref>&#160;are to be used in the context literally expressed in the phrase ascribed to the code, i.e. the use of an indexing code is neither restricted by its hierarchical position in a group nor by the definition of the group in which the code is found.</paragraph-text></list-item></list><paragraph-text type="subheading">C-Sets syntax rules:</paragraph-text><list><list-item><paragraph-text type="body">Each C-Set shall contain at least two symbols.</paragraph-text></list-item><list-item><paragraph-text type="body">Duplicate symbols are not allowed in these C-Sets. </paragraph-text></list-item><list-item><paragraph-text type="body">The order of symbols in the C-Sets is relevant as it reflects the methods or process as a base symbol and as a subsequent symbol, which are displayed in alphanumerical order. </paragraph-text></list-item></list><paragraph-text type="subheading">C-Sets examples:</paragraph-text><list><list-item><paragraph-text type="body">#C12Nb: A method for inserting a gene of interest into a vector (<class-ref scheme="cpc">C12N15/66</class-ref>) using a type IIS restriction enzyme (<class-ref scheme="cpc">C12Q2521/313</class-ref>), and a ligase (<class-ref scheme="cpc">C12Q2521/501</class-ref>) to attach an adaptor (<class-ref scheme="cpc">C12Q2525/191</class-ref>) at each extremity of the gene of interest is classified as (<class-ref scheme="cpc">C12N15/66</class-ref>, <class-ref scheme="cpc">C12Q2521/313</class-ref>, <class-ref scheme="cpc">C12Q2521/501</class-ref>, <class-ref scheme="cpc">C12Q2525/191</class-ref>).</paragraph-text></list-item><list-item><paragraph-text type="body">#C12Nb: A method for preparing a vector (<class-ref scheme="cpc">C12N15/64</class-ref>) comprising amplifying a template using strand-displacement rolling circle (<class-ref scheme="cpc">C12Q2531/125</class-ref>) is classified as (<class-ref scheme="cpc">C12N15/64</class-ref>, <class-ref scheme="cpc">C12Q2531/125</class-ref>).</paragraph-text></list-item></list></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/65</classification-symbol><definition-title>using markers  (enzymes used as markers <class-ref scheme="cpc">C12N15/52</class-ref>)</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host using polypeptides as marker molecules, wherein the polypeptides do not comprise enzymatic activity.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Enzymes used as marker molecules</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/52</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/00</class-ref> group.</paragraph-text><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/10</class-ref> group.</paragraph-text><paragraph-text type="body">The methods or processes should always be classified in combination-sets which consist of the appropriate CPC group together with the Indexing Codes under <class-ref scheme="cpc">C12N2500/00</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/66</classification-symbol><definition-title>General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General method for preparing a recombinant vector using cleavage and ligation.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/00</class-ref> group.</paragraph-text><paragraph-text type="body">See corresponding header for the <class-ref scheme="cpc">C12N15/10</class-ref> group.</paragraph-text><paragraph-text type="body">The methods or processes should always be classified in combination-sets which consist of the appropriate CPC group together with the Indexing Codes under <class-ref scheme="cpc">C12N2500/00</class-ref>.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Non-functional linkers</paragraph-text></table-column><table-column><paragraph-text type="body">DNA sequences which are used to link DNA sequences and which have no known function of structural gene or regulating function.</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/67</classification-symbol><definition-title>General methods for enhancing the expression</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General method for ribosome mediated regulating (i.e. enhancing, inhibiting) the gene expression by modifying the ribosomal mediated translation of the messenger RNA.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Transcriptional regulation of gene expression</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/63</class-ref>, <class-ref scheme="cpc">C12N15/635</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/68</classification-symbol><definition-title>Stabilisation of the vector</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General method of enhancing the expression a nucleic acid sequence, by stabilizing the vector in the host cell, e.g. preserving DNA in a stable form over time, temperature, culture conditions.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/69</classification-symbol><definition-title>Increasing the copy number of the vector</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">General method of enhancing the expression a nucleic acid sequence, by increasing the copy number of the vector in the host cell, e.g. conditions that results in an increase in plasmid copy number in comparison to a control plasmid, e.g. mutation in the copy number control region.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/70</classification-symbol><definition-title>Vectors or expression systems specially adapted for E. coli</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for E.coli, i.e. comprising at least one origin of replication working in Escherichia coli.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Shuttle vector is classified according to the vector/host system in which the vector is able to replicate.</paragraph-text><paragraph-text type="body">Vectors comprising a chimeric/hybrid origin of replication are classified according to the vectors/host system in which the vector is able to replicate.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Shuttle vector</paragraph-text></table-column><table-column><paragraph-text type="body">Vector comprising at least two different origins of replication</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/71</classification-symbol><definition-title>Expression systems using regulatory sequences derived from the trp-operon</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for E.coli, i.e. comprising at least one origin of replication working in Escherichia coli, and comprising regulatory sequences from the trp-operon.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Trp-operon</paragraph-text></table-column><table-column><paragraph-text type="body">Tryprophan-operon</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Operon</paragraph-text></table-column><table-column><paragraph-text type="body">Set of neighbouring prokaryotic genes whose transcription is simultaneously controlled</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/72</classification-symbol><definition-title>Expression systems using regulatory sequences derived from the lac-operon</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for E.coli, i.e. comprising at least one origin of replication working in Escherichia coli, and comprising regulatory sequences from the lac-operon.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text></section-body></special-rules><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Lac-operon</paragraph-text></table-column><table-column><paragraph-text type="body">Lactose-operon</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/73</classification-symbol><definition-title>Expression systems using phage (lambda) regulatory sequences</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for E.coli, i.e. comprising at least one origin of replication working in Escherichia coli, and comprising regulatory sequences from the phage (lambda) regulatory sequences.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/74</classification-symbol><definition-title>Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for prokaryotic hosts other than E.coli, i.e. comprising at last one origin of replication working in prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/743</classification-symbol><definition-title>{for Agrobacterium; Rhizobium; Bradyrhizobium}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for prokaryotic hosts other than E.coli, i.e. comprising at least one origin of replication working in prokaryotic hosts other than E. coli, e.g. for Agrobacterium, Rhizobium, Bradyrhizobium.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/746</classification-symbol><definition-title>{for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for prokaryotic hosts other than E.coli, i.e. comprising at least one origin of replication working in prokaryotic hosts other than E. coli, e.g.: for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus).</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/75</classification-symbol><definition-title>for Bacillus</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for prokaryotic hosts other than E.coli, i.e. comprising at least one origin of replication working in prokaryotic hosts other than E. coli, e. g. for Bacillus.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header fro <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/76</classification-symbol><definition-title>for Actinomyces; for Streptomyces</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for prokaryotic hosts other than E.coli, i.e. comprising at least one origin of replication working in prokaryotic hosts other than E. coli, e. g. for Actinomyces; for Streptomyces.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/77</classification-symbol><definition-title>for Corynebacterium; for Brevibacterium</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for prokaryotic hosts other than E.coli, i.e. comprising at least one origin of replication working in prokaryotic hosts other than E. coli, e. g. Corynebacterium, for Brevibacterium.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/78</classification-symbol><definition-title>for Pseudomonas</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for prokaryotic hosts other than E.coli, i.e. comprising at least one origin of replication working in prokaryotic hosts other than E. coli, e. g. Pseudomonas.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/79</classification-symbol><definition-title>Vectors or expression systems specially adapted for eukaryotic hosts</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for eukaryotic hosts, i.e. comprising at least one origin of replication working in eukaryotic hosts, and which can not be classified in the subgroups below <class-ref scheme="cpc">C12N15/80</class-ref> &#8211; <class-ref scheme="cpc">C12N15/86</class-ref>.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/64</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/80</classification-symbol><definition-title>for fungi</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for eukaryotic hosts, i.e. comprising at least origin of replication working in eukaryotic hosts, e.g. fungi.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/64</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/81</classification-symbol><definition-title>for yeasts</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for eukaryotic hosts, i.e. comprising at least one origin of replication working in eukaryotic hosts, e.g. yeast.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/64</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/815</classification-symbol><definition-title>{for yeasts other than Saccharomyces}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All application dealing with vectors especially adapted for eukaryotic hosts, i.e. comprising at least one origin of replication working in eukaryotic hosts, e.g. other than Saccharomyces.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/70</class-ref>.</paragraph-text><paragraph-text type="body">See corresponding header for <class-ref scheme="cpc">C12N15/64</class-ref>.</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/82</classification-symbol><definition-title>for plant cells {, e.g. plant artificial chromosomes (PACs)}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><list><list-item><paragraph-text type="body">New transgenic plants, methods, vectors, constructs, promoters, etc. for transforming, expressing;</paragraph-text></list-item><list-item><paragraph-text type="body">Modifying genotypes/phenotypes of plants by genetic engineering.</paragraph-text></list-item></list></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body">If a document relates to:</paragraph-text><paragraph-text type="body">Plant breeding (tissue culture) method and new non-transgenic plants (varieties): use <class-ref scheme="cpc">A01H1/00</class-ref> through <class-ref scheme="cpc">A01H4/00</class-ref> for the method if appropriate; use <class-ref scheme="cpc">A01H5/00</class-ref> through <class-ref scheme="cpc">A01H17/00</class-ref> for the new plants (varieties)</paragraph-text><list><list-item><paragraph-text type="body">Purposive modification of plant phenotype/genotype (e.g. method for altering starch composition), creation of transgenic plants and transgenic plants themselves: use <class-ref scheme="cpc">C12N15/8241</class-ref>... subclass for the method if appropriate;use <class-ref scheme="cpc">C12N15/8241</class-ref>... subclass as appropriate for the plant if transgenic normally no <class-ref scheme="cpc">A01H</class-ref> class (<class-ref scheme="cpc">A01H</class-ref> class could be given if there is information regarding the transgenic plant as a variety)</paragraph-text></list-item><list-item><paragraph-text type="body">Transformation method or expression method (including constructs, promoters etc): use <class-ref scheme="cpc">C12N15/8201</class-ref>... or <class-ref scheme="cpc">C12N15/8216</class-ref>... for the methods as appropriate</paragraph-text></list-item></list><paragraph-text type="body">Note that the <class-ref scheme="cpc">C12N15/8241</class-ref>... subclasses are not used unless there is significant matter defining the purposive modification of the plant genotype or phenotype normally no <class-ref scheme="cpc">A01H</class-ref> class as above. (Note also <class-ref scheme="cpc">A01H1/00</class-ref> through <class-ref scheme="cpc">A01H4/00</class-ref> could be added. For example if transformation method included information relating to tissue culture).</paragraph-text><paragraph-text type="body"><class-ref scheme="cpc">A01H5/00</class-ref> through <class-ref scheme="cpc">A01H17/00</class-ref> classes are only used in ECLA for new mainly non-transgenic plants (usually varieties).</paragraph-text></section-body></relationship><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">Includes algal transformation</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/8213</classification-symbol><definition-title>{Targeted insertion of genes into the plant genome by homologous recombination}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Means for DNA/chromosomal rearrangements</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/8214</classification-symbol><definition-title>{Plastid transformation}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Mitochondrial transformation</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/8217</classification-symbol><definition-title>{Gene switch}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Multiple cis/trans cascaded systems</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/8221</classification-symbol><definition-title>{Transit peptides}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Signal peptides</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/8242</classification-symbol><definition-title>{with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits}</definition-title><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><paragraph-text type="body">Output trait influences the output products of plants or their parts</paragraph-text></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/8251</classification-symbol><definition-title>{Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis}</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Modulating protein content</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N15/8261</classification-symbol><definition-title>{with agronomic (input) traits, e.g. crop yield}</definition-title><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><paragraph-text type="body">Input trait influences the input required for growth and development of the plant or its parts</paragraph-text></section-body></glossary-of-terms></definition-item>
<definition-item date-revised="2025-01-01"><classification-symbol scheme="cpc">C12N15/85</classification-symbol><definition-title>for animal cells</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Vectors are nucleic acid constructs capable of introducing genetic information into cells.This group covers vectors for animal cells (<class-ref scheme="cpc">C12N15/85</class-ref>), in particular for the production of transgenic animals (<class-ref scheme="cpc">C12N15/8509</class-ref>), and viral vectors (<class-ref scheme="cpc">C12N15/86</class-ref>).</paragraph-text><paragraph-text type="body">Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation, cloning and microinjection are covered by <class-ref scheme="cpc">C12N15/87</class-ref>-<class-ref scheme="cpc">C12N15/907</class-ref>.</paragraph-text></section-body></definition-statement><relationship><section-title>Relationships with other classification places</section-title><section-body><paragraph-text type="body"><class-ref scheme="cpc">C12N15/8509</class-ref>, <class-ref scheme="cpc">C12N15/873</class-ref> and <class-ref scheme="cpc">C12N15/877</class-ref> relate to processes for producing animals, which per se are classified in the range <class-ref scheme="cpc">A01K67/027</class-ref>-<class-ref scheme="cpc">A01K67/60</class-ref>, in combination with codes in the <class-ref scheme="cpc">A01K2207/00</class-ref>-<class-ref scheme="cpc">A01K2267/00</class-ref> ranges.</paragraph-text></section-body></relationship><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Vectors specialised for bacterial cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/70</class-ref> - <class-ref scheme="cpc">C12N15/78</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Vectors specialised for yeast cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/80</class-ref>- <class-ref scheme="cpc">C12N15/81</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Vectors specialised for plant cells</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/82</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><list><list-item><paragraph-text type="body">For all vectors listed below, the relevant uses and functional elements should be indicated using codes in the <class-ref scheme="cpc">C12N2800/00</class-ref>-<class-ref scheme="cpc">C12N2840/00</class-ref> ranges unless indicated otherwise.</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N15/85</class-ref> is to be given when a vector is particularly suitable for introduction of genetic material into animal cells.</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N15/8509</class-ref> is to be combined with codes in the <class-ref scheme="cpc">A01K2267/00</class-ref> series to indicate the particular purpose of the produced animal model. <class-ref scheme="cpc">A01K67/027</class-ref>-<class-ref scheme="cpc">A01K67/60</class-ref> is to be given if the animal has actually been generated. In these cases, (a) code(s) in the <class-ref scheme="cpc">A01K2217/00</class-ref> range are to be used to further define the vector and animal. With respect to the use of codes in the <class-ref scheme="cpc">C12N2830/00</class-ref> range in combination with <class-ref scheme="cpc">C12N15/8509</class-ref> classes, <class-ref scheme="cpc">A01K2217/203</class-ref> takes precedence over <class-ref scheme="cpc">C12N2830/001</class-ref> and <class-ref scheme="cpc">C12N2830/007</class-ref>, and <class-ref scheme="cpc">A01K2217/206</class-ref> takes precedence over <class-ref scheme="cpc">C12N2830/008</class-ref>. The <class-ref scheme="cpc">C12N2830/001</class-ref>-<class-ref scheme="cpc">C12N2830/008</class-ref> codes are only to be given when the invention actually resides in these elements. <class-ref scheme="not-mapped">C12N27xx/xxx43</class-ref> (where x is an integer from 0 to 9) codes are to be given to combine viral taxonomy with vector use in generating genetically modified animals.</paragraph-text></list-item><list-item><paragraph-text type="body">The subdivision of viral vectors corresponding to IPC <class-ref scheme="cpc">C12N15/86</class-ref> and subclasses is no longer used. It is mandatory to give symbols from the <class-ref scheme="cpc">C12N2710/00</class-ref>-<class-ref scheme="cpc">C12N2795/00</class-ref> series combining the viral taxonomy with the appropriate ending 43, 44 or 45 to indicate subject-matter relating to viral vectors. When the viral vector is an essential part of the invention, <class-ref scheme="cpc">C12N15/86</class-ref> needs to be co-allocated.</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N15/87</class-ref> and <class-ref scheme="cpc">C12N15/88</class-ref> relate to introduction of foreign genetic material by processes not otherwise provided for, whereby the vectors of <class-ref scheme="cpc">C12N15/88</class-ref> are microencapsulated. If such subject-matter is for therapeutic use, gene therapy (<class-ref scheme="cpc">A61K48/00</class-ref>) and relevant non-active ingredients need to be considered (<class-ref scheme="cpc">A61K47/00</class-ref>). For microencapsulation, the liposome composition may be of relevance (<class-ref scheme="cpc">A61K9/127</class-ref>).</paragraph-text></list-item><list-item><paragraph-text type="body">Processes for the production of new or cloned embryos are to be classified in <class-ref scheme="cpc">C12N15/873</class-ref> and <class-ref scheme="cpc">C12N15/877</class-ref>. If new animals have been actually produced, also the relevant <class-ref scheme="cpc">A01K67/027</class-ref>-<class-ref scheme="cpc">A01K67/60</class-ref> class and relevant codes in the <class-ref scheme="cpc">A01K2207/00</class-ref>-<class-ref scheme="cpc">A01K2267/00</class-ref> ranges are to be given. For the manipulation of cells, <class-ref scheme="cpc">C12N5/00</class-ref> groups should be considered.</paragraph-text></list-item><list-item><paragraph-text type="body"><class-ref scheme="cpc">C12N15/89</class-ref> and subgroups relate to processes for introduction of foreign genetic material by microinjection, in particular using biolistic methods (<class-ref scheme="cpc">C12N15/895</class-ref>).</paragraph-text></list-item><list-item><paragraph-text type="body">Vectors for homologous recombination are classified in <class-ref scheme="cpc">C12N15/902</class-ref>, with specific subdivision for yeast (<class-ref scheme="cpc">C12N15/905</class-ref>) and mammalian cells (<class-ref scheme="cpc">C12N15/907</class-ref>). The last place rule applies.</paragraph-text></list-item><list-item><paragraph-text type="body">Introduction of genetic material specifically into plant cells should also be classified in <class-ref scheme="cpc">C12N15/82</class-ref> and subgroups.</paragraph-text></list-item></list></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12N2310/00</classification-symbol><definition-title>Structure or type of the nucleic acid</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All indexing information needed to characterise the non-coding nucleic acids used in groups <class-ref scheme="cpc">C12N15/11</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12N15/117</class-ref>.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Specific uses or applications</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2320/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Ways of production or obtention</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2330/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The orthogonal Indexing symbols in this group are only to be used with groups&#160;<class-ref scheme="cpc">C12N15/11</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12N15/117</class-ref>.</paragraph-text><paragraph-text type="body">The orthogonal Indexing symbols are only given to information relevant to the invention or explicitly exemplified, i.e. wish-lists are not indexed.</paragraph-text><paragraph-text type="subheading">C-Sets classification: </paragraph-text><paragraph-text type="subheading">C-Sets statement: #C12Nc</paragraph-text><list><list-item><paragraph-text type="body">In groups <class-ref scheme="cpc">C12N2310/00</class-ref> - <class-ref scheme="cpc">C12N2310/533</class-ref>, a combination of features characterising the structure or type of the nucleic acid can be classified in the form of C-Sets when appropriate.</paragraph-text></list-item><list-item><paragraph-text type="body">In these C-Sets, the base symbol, representing the structure or type of the nucleic acid, is taken from the groups <class-ref scheme="cpc">C12N2310/00</class-ref> - <class-ref scheme="cpc">C12N2310/533</class-ref>, followed by a subsequent symbol representing a further characteristic of said nucleic acid is selected from the groups <class-ref scheme="cpc">C12N2310/00</class-ref> - <class-ref scheme="cpc">C12N2330/51</class-ref>.</paragraph-text></list-item></list><paragraph-text type="subheading">C-Sets syntax rules:</paragraph-text><list><list-item><paragraph-text type="body">Each C-Set shall contain at least two symbols.</paragraph-text></list-item><list-item><paragraph-text type="body">Duplicate symbols are not allowed in these C-Sets. </paragraph-text></list-item><list-item><paragraph-text type="body">The C-Sets is allocated as ADD.</paragraph-text></list-item><list-item><paragraph-text type="body">The order of symbols in these C-Sets is not relevant.</paragraph-text></list-item></list><paragraph-text type="subheading">C-Sets Examples:</paragraph-text><paragraph-text type="body">#C12Nc: a nucleic acid that is modified at the 2&apos;-OR position of the sugar by a methoxy-group: is classified as (<class-ref scheme="cpc">C12N2310/321</class-ref>, <class-ref scheme="cpc">C12N2310/3521</class-ref>) </paragraph-text><paragraph-text type="body">#C12Nc: a nucleic acid that is halogenated at the 2&apos;-R-position of the sugar is classified as (<class-ref scheme="cpc">C12N2310/322</class-ref>, <class-ref scheme="cpc">C12N2310/3533</class-ref>)</paragraph-text><paragraph-text type="body">#C12Nc: a methylated adenosine is classified as (<class-ref scheme="cpc">C12N2310/333</class-ref>, <class-ref scheme="cpc">C12N2310/3521</class-ref>) </paragraph-text><paragraph-text type="body">#C12Nc: an interfering RNA with a stem-loop structure, e.g. a shRNA is classified as (<class-ref scheme="cpc">C12N2310/14</class-ref>, <class-ref scheme="cpc">C12N2310/531</class-ref>) </paragraph-text><paragraph-text type="body">#C12Nc: an antisense nucleic acid with an LNA - gapmer design is classified as (<class-ref scheme="cpc">C12N2310/11</class-ref>, <class-ref scheme="cpc">C12N2310/3231</class-ref>, <class-ref scheme="cpc">C12N2310/341</class-ref>)</paragraph-text><paragraph-text type="subheading">C-Sets searches:</paragraph-text><paragraph-text type="body">C-Sets search queries may be made according to C-Sets classification rule #C12Nc described above. </paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2017-05-01"><classification-symbol scheme="cpc">C12N2310/10</classification-symbol><definition-title>Type of nucleic acid</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Information about which class of non-coding nucleic acid is concerned.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">The chemical structure of the nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/30</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">The physical structure of the nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/50</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2024-08-01"><classification-symbol scheme="cpc">C12N2310/18</classification-symbol><definition-title>acting by a non-sequence specific mechanism</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Structure or type of nucleic acid, Aptamers</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/16</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Structure or type of Immunomodulatory nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/17</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12N2310/30</classification-symbol><definition-title>Chemical structure</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Chemical modification of the nucleic acids, i.e. all relevant deviations from the natural DNA or RNA forms.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Type of nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">The physical structure of the nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/50</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Chemical modification of nucleotides and nucleosides</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C07H</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N2310/31</classification-symbol><definition-title>of the backbone</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Modifications of the phosphate group(s) forming the backbone of the nucleic acid, including the terminal group(s).</paragraph-text><paragraph-text type="body"><media id="media0.png" file-name="cpc-def-C12N-0000.png" type="png" preferred-width="4.52cm" preferred-height="4.1cm"/></paragraph-text></section-body></definition-statement><glossary-of-terms><section-title>Glossary of terms</section-title><section-body><paragraph-text type="preamble">In this place, the following terms or expressions are used with the meaning indicated:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Phosphonate</paragraph-text></table-column><table-column><paragraph-text type="body">O=P(O)2-R</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Phosphorodithioate</paragraph-text></table-column><table-column><paragraph-text type="body">S=P(O)2-SR, S=P(SO)-OR</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Phosphorothioate</paragraph-text></table-column><table-column><paragraph-text type="body">S=P(O)2-OR, O=P(O)2-SR</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Phosphoramidate</paragraph-text></table-column><table-column><paragraph-text type="body">O=P(O)2-NR2, O=P(NO)-OR</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Phosphotriester</paragraph-text></table-column><table-column><paragraph-text type="body">O=P(O)2-O-R</paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Phosphonothioate</paragraph-text></table-column><table-column><paragraph-text type="body">S= P(O)2-R</paragraph-text></table-column></table-row></table></section-body></glossary-of-terms></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N2310/318</classification-symbol><definition-title>where the PO2 is completely replaced, e.g. MMI or formacetal</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Nucleic acids where the phosphate units of the backbone are (at least partially) replaced by a different chemical entity.</paragraph-text></section-body></definition-statement></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N2310/32</classification-symbol><definition-title>of the sugar</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All modifications made to, or variations of, the (deoxy)ribose part of the nucleic acid:</paragraph-text><paragraph-text type="body"><media id="media1.png" file-name="cpc-def-C12N-0001.png" type="png" preferred-width="3.1cm" preferred-height="3.33cm"/></paragraph-text></section-body></definition-statement></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12N2310/321</classification-symbol><definition-title>2&apos;-O-R Modification</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All modifications at the 2&apos;-position of the sugar made via an oxygen-atom.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Modified sugar ring structures</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/323</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The nature of the modifying group is further defined by using a combination symbol (see the corresponding header of <class-ref scheme="cpc">C12N2310/00</class-ref>).</paragraph-text><paragraph-text type="body">The combination symbol corresponding to the natural ribose (2&apos;-OH), i.e. <class-ref scheme="cpc">C12N2310/321</class-ref> combined with <class-ref scheme="cpc">C12N2310/3531</class-ref> to form a combination set is only given when the RNA nature of the oligonucleotide is of particular relevance to the invention.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12N2310/322</classification-symbol><definition-title>2&apos;-R Modification</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All modifications directly linked to the 2&apos;-carbon of the sugar, without an intermediate oxygen.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Modified sugar ring structures</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/323</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The nature of the modifying group is further defined by using a combination symbol (see the corresponding header of <class-ref scheme="cpc">C12N2310/00</class-ref>).</paragraph-text><paragraph-text type="body">The combination symbol corresponding to the natural deoxyribose (2&apos;-H), i.e. <class-ref scheme="cpc">C12N2310/322</class-ref> combined with <class-ref scheme="cpc">C12N2310/3531</class-ref> to form a combination set is only given when the DNA nature of the oligonucleotide is of particular relevance to the invention.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12N2310/323</classification-symbol><definition-title>modified ring structure</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Modifications of the classical (deoxy)ribose ring, including replacement by other sugars.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Modifications made at positions of the sugar not affecting the (deoxy)ribose nature</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/321</class-ref>, <class-ref scheme="cpc">C12N2310/322</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The nature of the modifying group is further defined by using a combination symbol (see the corresponding header of <class-ref scheme="cpc">C12N2310/00</class-ref>).</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12N2310/33</classification-symbol><definition-title>of the base</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Nucleic acids comprising a base other than adenine (A), uracil (U), thymidine (T), guanine (G) or cytosine (C). This includes modifications of said natural bases.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Nucleic acids where one or more base(s) is (are) missing</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/332</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The nature of the modifying group is further defined by using a combination symbol (see the corresponding header of <class-ref scheme="cpc">C12N2310/00</class-ref>).</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12N2310/34</classification-symbol><definition-title>Spatial arrangement of the modifications</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Nucleic acids where the specific position of a modification within the nucleic acid is relevant.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Modifications of the backbone, sugars or bases per se</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/31</class-ref>, <class-ref scheme="cpc">C12N2310/32</class-ref>, <class-ref scheme="cpc">C12N2310/33</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2021-08-01"><classification-symbol scheme="cpc">C12N2320/00</classification-symbol><definition-title>Applications; Uses</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Aspects concerning specific uses of the non-coding nucleic acids.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Structural aspects of the nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Methods for producing or obtaining the nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2330/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">2ND medical uses</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K31/7088</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Gene therapy</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The indexing symbols in this group are only to be used with groups <class-ref scheme="cpc">C12N15/11</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12N15/117</class-ref>.</paragraph-text><paragraph-text type="body">The indexing symbols are only given to information relevant to the invention or explicitly exemplified, i.e. wish-lists are not indexed.</paragraph-text><paragraph-text type="body">When appropriate, use of combination-symbols is made to further characterise the nucleic acids (see corresponding rule by <class-ref scheme="cpc">C12N2310/00</class-ref>).</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N2320/10</classification-symbol><definition-title>in screening processes</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">The use of the non-coding nucleic acid for screening as well as the detection of the nucleic acid.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Use of nucleic acids in screening</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2022-05-01"><classification-symbol scheme="cpc">C12N2320/11</classification-symbol><definition-title>for the determination of target sites, i.e. of active nucleic acids</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">The use of a non-coding nucleic acid in the identification of an accessible site on the target nucleic acid. Hence, the Indexing Code covers also the screening for active non-coding nucleic acids.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">The use in functional genomics</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2320/12</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Assays involving nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12Q1/68</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N2320/13</classification-symbol><definition-title>in a process of directed evolution, e.g. SELEX, acquiring a new function</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">All methods and processes directed to provide the non-coding nucleic acid with a new function.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">SELEX</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/1048</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N2320/30</classification-symbol><definition-title>Special therapeutic applications</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Subject-matter where the method or therapeutic application is part of the invention.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Pharmaceutical compositions comprising the nucleic acids; second therapeutic applications</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K31/7088</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Gene therapy</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">A61K48/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N2320/50</classification-symbol><definition-title>Methods for regulating/modulating their activity</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Methods and means directed to modify the natural activity of the nucleic acids.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">The directed acquisition of a totally new activity</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2320/13</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references></references></definition-item>
<definition-item date-revised="2016-08-01"><classification-symbol scheme="cpc">C12N2330/00</classification-symbol><definition-title>Production</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">The means for producing or obtaining the non-coding nucleic acids.</paragraph-text></section-body></definition-statement><references><section-title>References</section-title><limiting-references><section-title>Limiting references</section-title><section-body><paragraph-text type="preamble">This place does not cover:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">The structural aspects of the nucleic acids</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2310/00</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Specific uses</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2320/00</class-ref></paragraph-text></table-column></table-row></table></section-body></limiting-references><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Methods for isolating or producing nucleic acids in general</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N15/10</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">The indexing symbols in this group are only to be used with groups <class-ref scheme="cpc">C12N15/11</class-ref>&#160;-&#160;<class-ref scheme="cpc">C12N15/117</class-ref>.</paragraph-text><paragraph-text type="body">The indexing symbols are only given to information relevant to the invention or explicitly exemplified, i.e. wish-lists are not indexed.</paragraph-text><paragraph-text type="body">When appropriate, use of combination-symbols is made to further characterise the nucleic acids (see corresponding rule by <class-ref scheme="cpc">C12N2310/00</class-ref>).</paragraph-text></section-body></special-rules></definition-item>
<definition-item><classification-symbol scheme="cpc">C12N2330/10</classification-symbol><definition-title>naturally occurring</definition-title><definition-statement><section-title>Definition statement</section-title><section-body><paragraph-text type="preamble">This place covers:</paragraph-text><paragraph-text type="body">Non-coding nucleic acids naturally present in a cell or organism.</paragraph-text></section-body></definition-statement><special-rules><section-title>Special rules of classification</section-title><section-body><paragraph-text type="body">This Indexing Code can be given as a combination code, e.g. <class-ref scheme="cpc">C12N2310/111</class-ref> combined with <class-ref scheme="cpc">C12N2330/10</class-ref> to form a combination set indicates a naturally occurring antisense.</paragraph-text></section-body></special-rules></definition-item>
<definition-item date-revised="2024-08-01"><classification-symbol scheme="cpc">C12N2500/10</classification-symbol><definition-title>Metals; Metal chelators</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Vitamins of cell culture medium</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2500/38</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2024-08-01"><classification-symbol scheme="cpc">C12N2500/22</classification-symbol><definition-title>Zinc; Zn chelators</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Insulin used in cell culture processes, e.g. differentiation</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2501/33</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2024-08-01"><classification-symbol scheme="cpc">C12N2500/30</classification-symbol><definition-title>Organic components</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Metals; Metal chelators</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2500/10</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Light metals, Calcium; Ca chelators; Calcitonin</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2500/14</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Transition metals, Iron; Fe chelators; Transferrin</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2500/24</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2024-08-01"><classification-symbol scheme="cpc">C12N2500/40</classification-symbol><definition-title>Nucleotides, nucleosides or bases</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Modulators of cAMP or cGMP, e.g. non-hydrolysable analogues, phosphodiesterase inhibitors, cholera toxin</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2501/01</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Anti-neoplasic drugs, anti-retroviral drugs, e.g. azacytidine, cyclophosphamide</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2501/06</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2024-08-01"><classification-symbol scheme="cpc">C12N2500/70</classification-symbol><definition-title>Undefined extracts</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Conditioned medium</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2502/00</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2024-08-01"><classification-symbol scheme="cpc">C12N2501/30</classification-symbol><definition-title>Hormones</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Hormones derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2501/85</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2024-08-01"><classification-symbol scheme="cpc">C12N2501/33</classification-symbol><definition-title>Insulin</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Insulin-transferrin; Insulin-transferrin-selenium</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2500/25</class-ref></paragraph-text></table-column></table-row>
<table-row><table-column><paragraph-text type="body">Insulin-like growth factors [IGF]</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2501/105</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2024-08-01"><classification-symbol scheme="cpc">C12N2501/72</classification-symbol><definition-title>Transferases [EC 2.]</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Modulators of histone acetylation</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2501/065</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item>
<definition-item date-revised="2024-08-01"><classification-symbol scheme="cpc">C12N2533/30</classification-symbol><definition-title>Synthetic polymers</definition-title><references><section-title>References</section-title><informative-references><section-title>Informative references</section-title><section-body><paragraph-text type="preamble">Attention is drawn to the following places, which may be of interest for search:</paragraph-text><table>
<table-row><table-column><paragraph-text type="body">Coating allowing for selective detachment of cells, e.g. thermoreactive coating</paragraph-text></table-column><table-column><paragraph-text type="body"><class-ref scheme="cpc">C12N2539/10</class-ref></paragraph-text></table-column></table-row></table></section-body></informative-references></references></definition-item></definitions>